• Aaseth J, Thomassen Y, Aadland E, Fausa O, Schrumpf E. Hepatic retention of copper and selenium in primary sclerosing cholangitis. Scand. J. Gastroenterol. 30: 1200-1203 (1995).

• Abdelmalek M, Ludwig J, Lindor KD. Two cases from the spectrum of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 20: 127-130 (1995).

• Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, Couturier D, Amor B. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 108: 417-422 (1995). *

• Ablin DS, Ziegler M. Ulcerative type of colitis associated with the use of high strength pancreatic enzyme supplements in cystic fibrosis. Pediatr. Radiol. 25: 113-115 (1995).

• Aburahma AF, Powell MA, Boland JP. A case study of abdominal angina secondary to celiac compression syndrome. W. V. Med. J. 91: 10-12 (1995).

• Aburano T. Radionuclide imaging in hepatobiliary disease. Kaku Igaku 32: 599-603 (1995).

• Accatino L, Figueroa C, Pizarro M, Solis N. Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver. J. Hepatol. 22: 658-670 (1995). *

• Acha-Orbea H, MacDonald HR. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13: 459-486 (1995). *

• Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM. Apoptosis in the human liver during allograft rejection and end-stage liver disease. J. Pathol. 176: 373-380 (1995).

• Aisenberg J, Wagreich J, Shim J, Almer S, Peen E, Heimann T, Gelernt IM, Greenstein A, Rubin P, Harpaz N, et al. Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis. A case-control study. Dig. Dis. Sci. 40: 1866-1872 (1995).

• Aitola P, Miettinen A, Mattila A, Matikainen M, Soppi E. Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. J. Clin. Pathol. 48: 645-647 (1995). *

• Aldersley MA, O'Grady JG. Hepatic disorders. Features and appropriate management. Drugs 49: 83-102 (1995).

• Alexander RJ, Panja A, Kaplan-Liss E, Mayer L, Raicht RF. Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease. Dig. Dis. Sci. 40: 485-494 (1995).

• Aliaga L, Mediavilla JD, Omar M, Zozaya JM, Prieto J. Directional velocity of the arterial flow, systemic vascular resistance and urinary excretion of sodium in cirrhotic patients. Presse. Med. 24: 758-762 (1995).

• Alper CA. The human immune response to hepatitis B surface antigen. Exp. Clin. Immunogenet. 12: 171-181 (1995).

• Alt M, Caselmann WH. Liver-directed gene therapy: molecular tools and current preclinical and clinical studies. J. Hepatol. 23: 746-758 (1995). *

• Alvarez R, de Andres J, Yubero P, Vinas O, Mampel T, Iglesias R, Giralt M, Villarroya F. A novel regulatory pathway of brown fat thermogenesis. Retinoic acid is a transcriptional activator of the mitochondrial uncoupling protein gene. J. Biol. Chem. 270: 5666-5673 (1995). *

• Alvaro D, Gigliozzi A, Piat C, Carli L, Bini A, La Rosa T, Furfaro S, Capocaccia L. Effect of S-adenosyl-L-methionine on ethanol cholestasis and hepatotoxicity in isolated perfused rat liver. Dig. Dis. Sci. 40: 1592-1600 (1995).

• Aoshima M, Nakamura K, Makino I. Conjugated bile acid profiles in serum, urine, and bile of patients with primary biliary cirrhosis under the ursodeoxycholic acid treatment. Hokkaido Igaku Zasshi 70: 57-67 (1995).

• Aoudjit F, Brochu N, Morin N, Poulin G, Stratowa C, Audette M. Heterodimeric retinoic acid receptor-beta and retinoid X receptor-alpha complexes stimulate expression of the intercellular adhesion molecule-1 gene. Cell Growth Differ. 6: 515-521 (1995).

• Arai T, Michalski JP, McCombs CC, Elston RC, McCarthy CF, Stevens FM. T cell receptor gamma gene polymorphisms and class II human lymphocyte antigen genotypes in patients with celiac disease from the west of Ireland. Am. J. Med. Sci. 309: 171-178 (1995).

• Arber N, Berliner S, Hallak A, Bujanover Y, Dotan I, Liberman E, Santo M, Moshkowitz M, Ratan J, Dotan G, et al. Increased leucocyte adhesiveness/aggregation is a most useful indicator of disease activity in patients with inflammatory bowel disease. Gut 37: 77-80 (1995). *

• Archimandritis A, Koumentakos P, Douvara M, Scandalis N, Fertakis A. GC and C3 serum groups in ulcerative colitis. Hum. Hered. 45: 215-218 (1995).

• Archimandritis A, Tjivras M, Tsirantonaki M, Hatzis G, Delladetsima I. Sjogren's syndrome with antimitochondrial antibody-negative primary biliary cirrhosis: a case of autoimmune cholangitis. J. Clin. Gastroenterol. 20: 268-270 (1995).

• Arndt H, Palitzsch KD, Anderson DC, Rusche J, Grisham MB, Granger DN. Leucocyte-endothelial cell adhesion in a model of intestinal inflammation. Gut 37: 374-379 (1995). *

• Arnett KL, Adams EJ, Gumperz JE, Darke C, Marsh SG, Gelsthorpe K, Parham P. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802]. Tissue Antigens 46: 316-321 (1995).

• Arrese M, Pizarro M, Solis N, Koenig C, Accatino L. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration. Biochem. Pharmacol. 50: 1223-1232 (1995).

• Asakura H, Sugimura K. HLA, antineutrophil cytoplasmic autoantibody, and heterogeneity in ulcerative colitis. Gastroenterology 108: 597-599 (1995). *

• Ascher NL. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Liver Transpl. Surg. 1: 256-257 (1995).

• Aspinall GO, Monteiro MA, Moran AP, Pang H, Penner JL, Shaver RT. Lipopolysaccharides from Helicobacter pylori. Prog. Clin. Biol. Res. 392: 93-101 (1995).

• Atkins KB, Troen BR. Regulation of cathepsin D gene expression in HL-60 cells by retinoic acid and calcitriol. Cell Growth Differ. 6: 871-877 (1995).

• Audan A, Bruley Des Varannes S, Georgelin T, Sagan C, Cloarec D, Serraz H, Le Bodic L. Primary sclerosing cholangitis and systemic lupus erythematosus. Gastroenterol. Clin. Biol. 19: 123-126 (1995).

• Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290 (1995). *

• Axon AT. Cancer surveillance in ulcerative colitis. Gut 36: 801 (1995). *

• Ayala A, Chaudry IH. Dietary n-3 polyunsaturated fatty acid modulation of immune cell function before or after trauma. Nutrition 11: 1-11 (1995).

• Azer SA, Canfield PJ, Stacey NH. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid. J. Gastroenterol. Hepatol. 10: 261-269 (1995).

• Bacq Y, Myara A, Brechot MC, Hamon C, Studer E, Trivin F, Metman EH. Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy. J. Hepatol. 22: 66-70 (1995). *

• Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J. Clin. Endocrinol. Metab. 80: 2112-2117 (1995). *

• Baker A, Gormally S, Saxena R, Baldwin D, Drumm B, Bonham J, Portmann B, Mowat AP. Copper-associated liver disease in childhood. J. Hepatol. 23: 538-543 (1995). *

• Balan V, LaRusso NF. Hepatobiliary disease in inflammatory bowel disease. Gastroenterol. Clin. North Am. 24: 647-669 (1995).

• Balasubramanian S, Chernov-Rogan T, Davis AM, Whitehorn E, Tate E, Bell MP, Zurawski G, Barrett RW. Ligand binding kinetics of IL-2 and IL-15 to heteromers formed by extracellular domains of the three IL-2 receptor subunits. Int. Immunol. 7: 1839-1849 (1995).

• Balducci-Silano PL, Layrisse ZE. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population. Associations with other HLA-alleles. J. Autoimmun. 8: 425-437 (1995).

• Bamba T, Matsuda H, Endo M, Fujiyama Y. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J. Gastroenterol. 30 Suppl. 8: 45-47 (1995).

• Banerjee AK, Steele RJ. Current views on the pathophysiology of acute biliary pancreatitis. Gut 36: 803-805 (1995). *

• Bansi DS, Fleming KA, Chapman RW. Antineutrophil cytoplasmic antibodies in autoimmune hepatitis. Gastroenterology 109: 2049-2050 (1995). *

• Bansil S, Cook SD, Rohowsky-Kochan C. Multiple sclerosis: immune mechanism and update on current therapies. Ann. Neurol. 37 Suppl. 1: S87-S101 (1995).

• Bar-Meir E, Teuber SS, Lin HC, Alosacie I, Goddard G, Terybery J, Barka N, Shen B, Peter JB, Blank M, et al. Multiple autoantibodies in patients with silicone breast implants. J. Autoimmun. 8: 267-277 (1995).

• Barthet M, Affriat C, Bernard JP, Berthezene P, Dagorn JC, Sahel J. Is biliary lithiasis associated with pancreatographic changes? Gut 36: 761-765 (1995). *

• Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J. Invest. Dermatol. 105: 89S-94S (1995).

• Batt AM, Ferrari L. Manifestations of chemically induced liver damage. Clin. Chem. 41: 1882-1887 (1995). *

• Bauditz J, Ruckert Y, Raedler A, Nikolaus S, Lochs H, Schreiber S. Tumour necrosis factor inhibition by oxpentifylline and intestinal inflammation in Crohn's disease. Lancet 345: 1445 (1995).

• Baum H. Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochim. Biophys. Acta 1271: 111-121 (1995).

• Bayerdorffer E, Mannes GA, Ochsenkuhn T, Dirschedl P, Wiebecke B, Paumgartner G. Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut 36: 268-273 (1995). *

• Beagley KW, Fujihashi K, Lagoo AS, Lagoo-Deenadaylan S, Black CA, Murray AM, Sharmanov AT, Yamamoto M, McGhee JR, Elson CO, et al. Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. J. Immunol. 154: 5611-5619 (1995).

• Bean P, Sutphin MS, Liu Y, Anton R, Reynolds TB, Shoenfeld Y, Peter JB. Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies. Clin. Chem. 41: 858-861 (1995).

• Becker D, Enk A, Brauninger W, Knop J. Granuloma anulare disseminatum as a rare side effect of allopurinol. Hautarzt. 46: 343-345 (1995).

• Beketic-Oreskovic L, Duran GE, Chen G, Dumontet C, Sikic BI. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. J. Natl. Cancer Inst. 87: 1593-1602 (1995).

• Bellary S, Hassanein T, Van Thiel DH. Liver transplantation for Wilson's disease. J. Hepatol. 23: 373-381 (1995). *

• Belle SH, Beringer KC, Detre KM. An update on liver transplantation in the United States: recipient characteristics and outcome. Clin. Transpl. 1995: 19-33 (1995).

• Ben Ari Z, Mehta A, Lennard L, Burroughs AK. Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis. J. Hepatol. 23: 351-354 (1995). *

• Benazet JF, Reviron D, Mercier P, Roux H, Roudier J. HLA-DRB1 alleles associated with rheumatoid arthritis in southern France. Absence of extraarticular disease despite expression of the shared epitope. J. Rheumatol. 22: 607-610 (1995).

• Bennetts BH, Teutsch SM, Heard RN, Dunckley H, Stewart GJ. TAP2 polymorphisms in Australian multiple sclerosis patients. J. Neuroimmunol. 59: 113-121 (1995).

• Berg PA, Klein R. Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited. Liver 15: 281-292 (1995).

• Berg PA, Klein R. Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis? J. Hepatol. 23: 103 (1995). *

• Bergasa NV. The pruritus of cholestasis. Semin. Dermatol. 14: 302-312 (1995).

• Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Turner ML, Schmitt JM, Walker EC, Jones EA. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann. Intern. Med. 123: 161-167 (1995). *

• Bergasa NV, Jones EA. The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids. Gastroenterology 108: 1582-1588 (1995). *

• Berkowitz CM, Shen CS, Bilir BM, Guibert E, Gumucio JJ. Different hepatocytes express the cholesterol 7 alpha-hydroxylase gene during its circadian modulation in vivo. Hepatology 21: 1658-1667 (1995).

• Berman E, Schlicht M, Moser VC, MacPhail RC. A multidisciplinary approach to toxicological screening: I. Systemic toxicity. J. Toxicol. Environ. Health 45: 127-143 (1995).

• Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J. Bone Miner. Res. 10: 250-256 (1995).

• Berrih-Aknin S. Myasthenia gravis, a model of organ-specific autoimmune disease. J. Autoimmun. 8: 139-143 (1995).

• Beuers U, Gerbes AL. Replacement therapy in primary biliary cirrhosis. Dtsch. Med. Wochenschr. 120: 1259-1260 (1995).

• Bhutani MS, Rostami G, Gopalswamy N. Hepatobiliary complications of inflammatory bowel disease. Am. Fam. Physician 52: 1440-1444 (1995).

• Biancone L, Mandal A, Yang H, Dasgupta T, Paoluzi AO, Marcheggiano A, Paoluzi P, Pallone F, Das KM. Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology 109: 3-12 (1995). *

• Biasco G, Brandi G, Paganelli GM, Rossini FP, Santucci R, Di Febo G, Miglioli M, Risio M, Morselli Labate AM, Barbara L. Colorectal cancer in patients with ulcerative colitis. A prospective cohort study in Italy. Cancer 75: 2045-2050 (1995).

• Bilik R, Superina RA, Phillips J, Edwards V. Prevention of biliary cirrhosis following hepatic arterial thrombosis after liver transplantation in children by using ursodeoxycholic acid. J. Pediatr. Surg. 30: 49-52 (1995).

• Billing P, Tahir S, Calfin B, Gagne G, Cobb L, Targan S, Vidrich A. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am. J. Pathol. 147: 979-987 (1995). *

• Billings PB, Keithley EM, Harris JP. Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann. Otol. Rhinol. Laryngol. 104: 181-188 (1995).

• Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Pena AS. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin. Exp. Immunol. 102: 379-383 (1995). *

• Bissonnette RP, Brunner T, Lazarchik SB, Yoo NJ, Boehm MF, Green DR, Heyman RA. 9-cis Retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol. Cell. Biol. 15: 5576-5585 (1995). *

• Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 108: 1566-1581 (1995). *

• Bloch DB, San Martin JE, Rauch SD, Moscicki RA, Bloch KJ. Serum antibodies to heat shock protein 70 in sensorineural hearing loss. Arch. Otolaryngol. Head Neck Surg. 121: 1167-1171 (1995).

• Bloom S, Fleming K, Chapman R. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. Gut 36: 604-609 (1995). *

• Bluestone JA, Khattri R, Sciammas R, Sperling AI. TCR gamma delta cells: a specialized T-cell subset in the immune system. Annu. Rev. Cell. Dev. Biol. 11: 307-353 (1995). *

• Bohr J, Tysk C, Eriksson S, Jarnerot G. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut 37: 394-397 (1995). *

• Boki KA, Dourakis SP. Polymyositis associated with primary biliary cirrhosis. Clin. Rheumatol. 14: 375-378 (1995).

• Bolton C. Recent advances in the pharmacological control of experimental allergic encephalomyelitis (EAE) and the implications for multiple sclerosis treatment. Mult. Scler. 1: 143-149 (1995).

• Borglum AD, Flint T, Madsen P, Celis JE, Kruse TA. Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21. Hum. Genet. 96: 592-596 (1995).

• Bortoluzzi F, Valentini M, Cernigoi C, Toffoli G, Boiocchi M, Poletti M, Sozzi M, Fornasarig M, Cannizzaro R, Bertolissi E. DNA flow cytometric evaluation of cell cycle distribution in ulcerative colitis: a proposed method for assessing severity of disease. Gut 36: 50-54 (1995). *

• Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med. 333: 1171-1175 (1995). *

• Botla R, Spivey JR, Aguilar H, Bronk SF, Gores GJ. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J. Pharmacol. Exp. Ther. 272: 930-938 (1995).

• Bouscarel B, Ceryak S, Robins SJ, Fromm H. Studies on the mechanism of the ursodeoxycholic acid-induced increase in hepatic low-density lipoprotein binding. Lipids 30: 607-617 (1995).

• Boutron MC, Faivre J, Quipourt V, Senesse P, Michiels C. Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut 37: 830-834 (1995). *

• Boy MF, La Nasa G, Balestrieri A, Cherchi MV, Usai P. Distribution of HLA-DPB1, -DQB1 -DQA1 alleles among Sardinian celiac patients. Dis. Markers 12: 199-204 (1995).

• Boylan JF, Lufkin T, Achkar CC, Taneja R, Chambon P, Gudas LJ. Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. Cell. Biol. 15: 843-851 (1995). *

• Brandtzaeg P, Farstad IN. Expression of adhesion molecules in human Peyer's patches. Gut 36: 944-945 (1995). *

• Brasitus TA. Primary chemoprevention strategies for colorectal cancer: ursodeoxycholic acid and other agents. Gastroenterology 109: 2036-2038 (1995). *

• Brenard R, Geubel A. Screening for primary biliary cirrhosis and primary sclerosing cholangitis. Influence of early diagnosis on therapeutic outcome. Acta Gastroenterol. Belg. 58: 422-425 (1995).

• Brennan FM, Maini RN, Feldmann M. Cytokine expression in chronic inflammatory disease. Br. Med. Bull. 51: 368-384 (1995).

• Brignola C, Belloli C, De Simone G, Varesco L, Walger P, Areni A, Calabrese C, Di Febo G, Barbara L. Familial adenomatous polyposis and inflammatory bowel disease associated in two kindreds. Dig. Dis. Sci. 40: 402-405 (1995).

• Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 36: 615-617 (1995). *

• Broome U, Lofberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis. Colon Rectum 38: 1301-1305 (1995).

• Broome U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22: 1404-1408 (1995).

• Brunner W. Pruritus - also a challenge in internal medicine. Schweiz. Med. Wochenschr. 125: 2244-2250 (1995).

• Brzezinski A, Rankin GB, Seidner DL, Lashner BA. Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease. Cleve. Clin. J. Med. 62: 317-323 (1995).

• Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, Hollander D, Gornbein J, Kopple JD, Vijayaroghavan SR. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J. Parenter. Enteral Nutr. 19: 453-460 (1995).

• Bunn CC, McMorrow M. Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies. Clin. Exp. Immunol. 102: 131-136 (1995). *

• Burg JR, Gist GL. The National Exposure Registry: procedures for establishing a registry of persons environmentally exposed to hazardous substances. Toxicol. Ind. Health 11: 231-248 (1995).

• Burgart LJ, Batts KP, Ludwig J, Nikias GA, Czaja AJ. Recent-onset autoimmune hepatitis. Biopsy findings and clinical correlations. Am. J. Surg. Pathol. 19: 699-708 (1995).

• Buskila D, Berezin M, Gur H, Lin HC, Alosachie I, Terryberry JW, Barka N, Shen B, Peter JB, Shoenfeld Y. Autoantibody profile in the sera of women with hyperprolactinemia. J. Autoimmun. 8: 415-424 (1995).

• Butler P, Hamilton-Miller J, Baum H, Burroughs AK. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem. Mol. Biol. Int. 35: 473-485 (1995).

• Butler P, Hamilton-Miller JM, McIntyre N, Burroughs AK. Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups. Gut 36: 931-934 (1995). *

• Byl B, Deviere J, Struelens MJ, Roucloux I, De Coninck A, Thys JP, Cremer M. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study. Clin. Infect. Dis. 20: 1236-1240 (1995).

• Caballero T, Nogueras F, Medina MT, Caracuel MD, de Sola C, Martinez-Salmeron FJ, Rodrigo M, Garcia del Moral R. Intraepithelial and lamina propria leucocyte subsets in inflammatory bowel disease: an immunohistochemical study of colon and rectal biopsy specimens. J. Clin. Pathol. 48: 743-748 (1995). *

• Cahill PA, Sitzmann JV. Nitric oxide and portal hypertension. J. Hepatol. 23: 355-356 (1995). *

• Caillat-Zucman S, Daniel S, Djilali-Saiah I, Timsit J, Garchon HJ, Boitard C, Bach JF. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus. Hum. Immunol. 44: 80-87 (1995).

• Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9: 401-412 (1995). *

• Calenoff E, Zhao JC, Derlacki EL, Harrison WH, Selmeczi K, Dutra JC, Olson IR, Hanson DG. Patients with Meniere's disease possess IgE reacting with herpes family viruses. Arch. Otolaryngol. Head Neck Surg. 121: 861-864 (1995).

• Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 346: 1117-1121 (1995).

• Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 37: 674-678 (1995). *

• Cantorna MT, Nashold FE, Hayes CE. Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur. J. Immunol. 25: 1673-1679 (1995).

• Cao MY, Gersdorff M, Deggouj N, Tomasi JP. The localization and specificity of guinea pig inner ear antigenic epitopes. J. Laryngol. Otol. 109: 19-23 (1995).

• Cao MY, Gersdorff M, Deggouj N, Warny M, Tomasi JP. Detection of inner ear disease autoantibodies by immunoblotting. Mol. Cell. Biochem. 146: 157-163 (1995).

• Cardona J, Houssin D, Gauthier F, Devictor D, Losay J, Hadchouel M, Bernard O. Liver transplantation in children with Alagille syndrome - a study of twelve cases. Transplantation 60: 339-342 (1995).

• Carlton VE, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum. Mol. Genet. 4: 1049-1053 (1995).

• Carper DA, Hohman TC, Old SE. Residues affecting the catalysis and inhibition of rat lens aldose reductase. Biochim. Biophys. Acta 1246: 67-73 (1995).

• Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J. Immunol. 154: 2434-2440 (1995).

• Caspi O, Polliack A, Klar R, Ben-Yehuda D. The association of inflammatory bowel disease and leukemia - coincidence or not? Leuk. Lymphoma 17: 255-262 (1995).

• Cassinotti P, Bas S, Siegl G, Vischer TL. Association between human parvovirus B19 infection and arthritis. Ann. Rheum. Dis. 54: 498-500 (1995). *

• Castellino F, Rosina F, Bansi DS, Bauducci M, Touscoz GA, Giorda L, Borghesio E, Bessone MP, Astegiano M, Musso A, et al. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? Eur. J. Gastroenterol. Hepatol. 7: 859-864 (1995).

• Cathebras PJ, Mosnier JF, Gouilloud S, Bouchou K, Rousset H. Hepatic granulomatosis in a patient with Graves' disease. Eur. J. Gastroenterol. Hepatol. 7: 905-908 (1995).

• Cavallini G, Frulloni L, Di Francesco V, Bovo P, Filippini M, Vaona B. Autoimmunity and chronic pancreatitis. Gut 36: 799-800 (1995). *

• Cawkwell L, Quirke P. A new class of colorectal cancer gene. Gut 36: 641-643 (1995). *

• Caygill CP, Hill MJ. Fish, n-3 fatty acids and human colorectal and breast cancer mortality. Eur. J. Cancer Prev. 4: 329-332 (1995).

• Chan CY, Huang YS, Wu JC, Lu RH, Hwang SJ, Wang YJ, Lee SD. Detection of antibody to M2 mitochondrial antigen in Chinese patients with primary biliary cirrhosis. Zhonghua Yi Xue Za Zhi (Taipei) 55: 214-218 (1995).

• Chang CH, Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765-767 (1995). *

• Chapman R. Does HLA status influence prognosis in primary sclerosing cholangitis? Gastroenterology 108: 937-940 (1995). *

• Chapman RW. The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon? Hepatology 21: 1473-1474 (1995).

• Chatte G, Streichenberger N, Boillot O, Gille D, Loire R, Cordier JF. Lymphocytic bronchitis/bronchiolitis in a patient with primary biliary cirrhosis. Eur. Respir. J. 8: 176-179 (1995).

• Chauffert M, Cisse A, Chevenne D, Parfait B, Michel S, Trivin F. HLA-DQ beta 1 typing and non-Asp57 alleles in the aborigine population of Senegal. Diabetes Care 18: 677-680 (1995).

• Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinarello CA. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154: 5492-5499 (1995).

• Chiba M, Iizuka M, Horie Y, Ishii N, Suzuki T, Masamune O. Further studies of HLA-DR antigens on colonic epithelium in ulcerative colitis. Tohoku J. Exp. Med. 177: 161-170 (1995).

• Chihiro M, Nagamoto H, Takemura I, Kitano K, Komatsu H, Sekiguchi K, Tabusa F, Mori T, Tominaga M, Yabuuchi Y. Novel thiazole derivatives as inhibitors of superoxide production by human neutrophils: synthesis and structure-activity relationships. J. Med. Chem. 38: 353-358 (1995).

• Choi PM, Kim WH. Colon cancer surveillance. Gastroenterol. Clin. North Am. 24: 671-687 (1995).

• Chou MJ, Lee SL, Chen TY, Tsay GJ. Specificity of antinuclear antibodies in primary biliary cirrhosis. Ann. Rheum. Dis. 54: 148-151 (1995). *

• Cicalese L, Duerr RH, Nalesnik MA, Heeckt PF, Lee KK, Schraut WH. Decreased mucosal IgA levels in ileum of patients with chronic ulcerative colitis. Dig. Dis. Sci. 40: 805-811 (1995). *

• Clapp DW, Freie B, Lee WH, Zhang YY. Molecular evidence that in situ-transduced fetal liver hematopoietic stem/progenitor cells give rise to medullary hematopoiesis in adult rats. Blood 86: 2113-2122 (1995). *

• Clapp DW, Freie B, Srour E, Yoder MC, Fortney K, Gerson SL. Myeloproliferative sarcoma virus directed expression of beta-galactosidase following retroviral transduction of murine hematopoietic cells. Exp. Hematol. 23: 630-638 (1995).

• Clapp DW, Williams DA. The use of umbilical cord blood as a cellular source for correction of genetic diseases affecting the hematopoietic system. Stem Cells 13: 613-621 (1995).

• Clausen MR, Mortensen PB. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut 37: 684-689 (1995). *

• Cofie MD DQ, Rogers MD R, Draelos MD FACE MT, Olansky MD FACE L, Scofield MD RH. Syndrome of type II polyglandular autoimmunity associated with HLA-DR4 in a large kindred, including HLA-DR3/DR4 heterozygosity in the probands, identical twins with identical manifestations. Endocr. Pract. 1: 395-398 (1995).

• Coll J, Palazon J, Yazbeck H, Gutierrez J, Aubo C, Benito P, Jagiello P, Maldyk H, Marrugat J, Anglada J, et al. Antibodies to human immunodeficiency virus (HIV-1) in autoimmune diseases: primary Sjogren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases. Clin. Rheumatol. 14: 451-457 (1995).

• Collins CE, Rampton DS. Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut 36: 5-8 (1995). *

• Colnot S, Lambert M, Blin C, Thomasset M, Perret C. Identification of DNA sequences that bind retinoid X receptor-1,25(OH)2D3-receptor heterodimers with high affinity. Mol. Cell. Endocrinol. 113: 89-98 (1995).

• Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD. HLA class II antigen associations help to define two types of alopecia areata. J. Am. Acad. Dermatol. 33: 757-764 (1995).

• Combes B, Carithers RL Jr, Maddrey WC, Lin D, McDonald MF, Wheeler DE, Eigenbrodt EH, Munoz SJ, Rubin R, Garcia-Tsao G, et al. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 22: 759-766 (1995).

• Connolly CS, Kantor GR, Menduke H. Hepatobiliary pruritus: what are effective treatments? J. Am. Acad. Dermatol. 33: 801-805 (1995).

• Coppel RL, Gershwin ME. Primary biliary cirrhosis: the molecule and the mimic. Immunol. Rev. 144: 17-49 (1995).

• Corzo D, Salazar M, Granja CB, Yunis EJ. Advances in HLA genetics. Exp. Clin. Immunogenet. 12: 156-170 (1995).

• Corzo D, Yunis JJ, Salazar M, Lieberman JA, Howard A, Awdeh Z, Alper CA, Yunis EJ. The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups. Blood 86: 3835-3840 (1995). *

• Costa C, Sambataro A, Baldi S, Modena V, Todros L, Libertucci D, Coni F, Fusaro E, Revello F, Murgia A, et al. Primary biliary cirrhosis: lung involvement. Liver 15: 196-201 (1995).

• Cotch MF, Fauci AS, Hoffman GS. HLA typing in patients with Wegener granulomatosis. Ann. Intern. Med. 122: 635 (1995).

• Cottone M, Cipolla C, Rosselli M. Epidemiology and pathogenesis of Crohn's disease. Chir. Ital. 47: 1-7 (1995).

• Counsell CE, Ruddell WS. Association between coeliac disease and autoimmune thyroid disease. Gut 36: 475-476 (1995). *

• Cox J. Inflammatory bowel disease: implications for the medical-surgical nurse. Medsurg. Nurs. 4: 427-434 (1995).

• Crippa G, Cagnoni C, Castelli A, Concesi C, Girometta S, Pancotti D, Sverzellati E, Tacchini G, Pierfranceschi MG, Carrara GC. Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis. Clin. Ter. 146: 367-372 (1995).

• Cristea A, Badea T, Bodizs G, Olinic N. Antineutrophil cytoplasmic autoantibodies (ANCA) - markers in diagnosis and monitoring systemic vasculitides. Rom. J. Intern. Med. 33: 37-46 (1995).

• Croft NM, Marshall TG, Ferguson A. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet 346: 1265-1267 (1995).

• Crosthwaite G, McKay C, Anderson JR. Laparoscopic subtotal cholecystectomy. J. R. Coll. Surg. Edinb. 40: 20-21 (1995).

• Cuddihy RM, Dutton CM, Bahn RS. A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5: 89-95 (1995).

• Cuthbert JA. Wilson's disease: a new gene and an animal model for an old disease. J. Investig. Med. 43: 323-336 (1995).

• Czaja AJ. Autoantibodies. Baillieres Clin. Gastroenterol. 9: 723-744 (1995).

• Czaja AJ. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig. Dis. Sci. 40: 435-456 (1995).

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis. Dig. Dis. Sci. 40: 2098-2106 (1995).

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108: 157-164 (1995). *

• Czaja AJ, Magrin S, Fabiano C, Fiorentino G, Diquattro O, Craxi A, Pagliaro L. Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis. Dig. Dis. Sci. 40: 33-40 (1995).

• Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am. J. Gastroenterol. 90: 1206-1211 (1995).

• Czaja AJ, Ming C, Shirai M, Nishioka M. Frequency and significance of antibodies to histones in autoimmune hepatitis. J. Hepatol. 23: 32-38 (1995). *

• Czaja AJ, Santrach PJ, Moore SB. HLA-DQ associations in type 1 autoimmune hepatitis. Mayo Clin. Proc. 70: 1154-1160 (1995). *

• D'Amico E, Paroli M, Fratelli V, Palazzi C, Barnaba V, Callea F, Consoli G. Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection. Dig. Dis. Sci. 40: 2113-2116 (1995).

• D'Argenio G, Biancone L, Cosenza V, Della Valle N, D'Armiento FP, Boirivant M, Pallone F, Mazzacca G. Transglutaminases in Crohn's disease. Gut 37: 690-695 (1995). *

• Dalton HR, Chapman RW. Role of biliary stenting in the management of bile duct stones in the elderly. Gut 36: 485-487 (1995). *

• Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis. Markers. 12: 127-133 (1995).

• Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, De Luca LM. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res. 55: 2774-2782 (1995). *

• Davies E, Hodgson HJ. Artificial livers - what's keeping them? Gut 36: 168-170 (1995). *

• Davies GR, Benson MJ, Gertner DJ, Van Someren RM, Rampton DS, Swain CP. Diagnostic and therapeutic push type enteroscopy in clinical use. Gut 37: 346-352 (1995). *

• Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 37: 580-584 (1995). *

• Davies MH, Ngong JM, Pean A, Vickers CR, Waring RH, Elias E. Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis. J. Hepatol. 22: 551-560 (1995). *

• Day DG. Feline cholangiohepatitis complex. Vet. Clin. North Am. Small Anim. Pract. 25: 375-385 (1995).

• de Beaux AC, Palmer KR, Carter DC. Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut 37: 121-126 (1995). *

• de Caestecker JS, Jazrawi RP, Nisbett JA, Joseph AE, Maxwell JD, Northfield TC. Direct assessment of the mechanism for a raised serum bile acid level in chronic liver disease. Eur. J. Gastroenterol. Hepatol. 7: 955-961 (1995).

• De Caterina R, Cybulsky MA, Clinton SK, Gimbrone MA Jr, Libby P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot. Essent. Fatty Acids 52: 191-195 (1995).

• de Gracia J, Miravitlles M, Vendrell M, Rodrigo MJ, Codina R, Morell F. IgG subclasses in patients with symptomatic IgA deficiency. Med. Clin. (Barc.) 104: 728-731 (1995).

• de Vries JE. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27: 537-541 (1995).

• De'Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD. Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am. J. Kidney Dis. 25: 380-389 (1995).

• Dean M, Allikmets R. Evolution of ATP-binding cassette transporter genes. Curr. Opin. Genet. Dev. 5: 779-785 (1995).

• Debinski HS, Lee CS, Danks JA, Mackenzie PI, Desmond PV. Localization of uridine 5'-diphosphate-glucuronosyltransferase in human liver injury. Gastroenterology 108: 1464-1469 (1995). *

• Delanghe JR, Duprez DA, De Buyzere ML, Bergez BM, Claeys LR, Leroux-Roels GG, Clement DL. Refractory hypertension is associated with the haptoglobin 2-2 phenotype. J. Cardiovasc. Risk 2: 131-136 (1995).

• Dentener MA, Francot GJ, Smit FT, Froon AH, Pennings HJ, Wouters EF, Buurman WA. Presence of bactericidal/permeability-increasing protein in disease: detection by ELISA. J. Infect. Dis. 171: 739-743 (1995).

• Desmet VJ. Histopathology of cholestasis. Verh. Dtsch. Ges. Pathol. 79: 233-240 (1995).

• Desombere I, Hauser P, Rossau R, Paradijs J, Leroux-Roels G. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes. J. Immunol. 154: 520-529 (1995).

• Dhote R, Christoforov B, Weill B, Menkes CJ. Joint and systemic manifestations related to type 2 anti-mitochondrial antibodies. Ann. Med. Interne. (Paris) 146: 536-540 (1995).

• Dias VC, Parsons HG. Modulation in delta 9, delta 6, and delta 5 fatty acid desaturase activity in the human intestinal CaCo-2 cell line. J. Lipid Res. 36: 552-563 (1995). *

• Dick T, Mierau R, Sternfeld R, Weiner EM, Genth E. Clinical relevance and HLA association of autoantibodies against the nucleolus organizer region (NOR-90). J. Rheumatol. 22: 67-72 (1995).

• Dickinson P, Dorin JR, Porteous DJ. Modelling cystic fibrosis in the mouse. Mol. Med. Today 1: 140-148 (1995).

• Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409 (1995). *

• Donn RP, Thomson W, Pepper L, Carthy D, Farhan A, Ryder C, Southwood T, Holt L, Ollier W. Antinuclear antibodies in early onset pauciarticular juvenile chronic arthritis (JCA) are associated with HLA-DQB1*0603: a possible JCA-associated human leucocyte antigen haplotype. Br. J. Rheumatol. 34: 461-465 (1995).

• Dray-Charier N, Paul A, Veissiere D, Mergey M, Scoazec JY, Capeau J, Brahimi-Horn C, Housset C. Expression of cystic fibrosis transmembrane conductance regulator in human gallbladder epithelial cells. Lab. Invest. 73: 828-836 (1995).

• Drosos AA, Moutsopoulos HM. Rheumatoid arthritis in Greece: clinical, serological and genetic considerations. Clin. Exp. Rheumatol. 13 Suppl. 12: S7-S12 (1995).

• Dubel L, Farges O, Bismuth H, Sebagh M, Homberg JC, Johanet C. Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis. J. Hepatol. 23: 674-680 (1995). *

• Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, Capron M, Colombel JF. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 37: 242-246 (1995). *

• Duclos-Vallee JC, Hadengue A, Ganne-Carrie N, Robin E, Degott C, Erlinger S. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A. Dig. Dis. Sci. 40: 1069-1073 (1995).

• Duerksen DR, Blondel-Hill E, Bailey RJ. Pneumocystis carinii pneumonia complicating methotrexate treatment of primary sclerosing cholangitis. Am. J. Gastroenterol. 90: 1886-1887 (1995).

• Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 108: 423-427 (1995). *

• Dugoujon JM, Cambon-Thomsen A. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity 22: 245-260 (1995).

• Duncan H, Swan C, Green J, Jones P, Brannigan K, Alldersea J, Fryer AA, Strange RC. Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin. Chim. Acta 240: 53-61 (1995).

• Duthie A, Doherty DG, Donaldson PT, Scott-Jupp R, Tanner MS, Eddleston AL, Mowat AP. The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis. J. Hepatol. 23: 532-537 (1995). *

• Dwarakanath AD, Campbell BJ, Tsai HH, Sunderland D, Hart CA, Rhodes JM. Faecal mucinase activity assessed in inflammatory bowel disease using 14C threonine labelled mucin substrate. Gut 37: 58-62 (1995). *

• Dwarakanath AD, Yu LG, Brookes C, Pryce D, Rhodes JM. 'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis. Gut 37: 585-588 (1995). *

• Dykhuizen RS, Brunt PW, Atkinson P, Simpson JG, Smith CC. Ecstasy induced hepatitis mimicking viral hepatitis. Gut 36: 939-941 (1995). *

• Eckhoff DE, Pirsch JD, D'Alessandro AM, Knechtle SJ, Young CJ, Geffner SR, Belzer FO, Kalayoglu M. Pretransplant status and patient survival following liver transplantation. Transplantation 60: 920-925 (1995).

• Egger SF, Huber-Spitzy V, Bohler K, Raff M, Scholda C, Barisani T, Vecsei VP. Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: clinical features, alterations of tearfilm and conjunctival flora. Acta Ophthalmol. Scand. 73: 355-357 (1995).

• Elasy T, Kaminsky D, Tracy M, Mehler PS. Allopurinol hypersensitivity syndrome revisited. West. J. Med. 162: 360-361 (1995). *

• Elsbach P, Weiss J. Prospects for use of recombinant BPI in the treatment of Gram-negative bacterial infections. Infect. Agents Dis. 4: 102-109 (1995).

• Elson CO, Holland SP, Dertzbaugh MT, Cuff CF, Anderson AO. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J. Immunol. 154: 1032-1040 (1995).

• Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 109: 1344-1367 (1995).

• Emmons LR, Schaub U, Hadziselimovic F. The incidence of colonic natural killer cells, large granular lymphocytes and mast cells in inflammatory bowel disease. Adv. Exp. Med. Biol. 371B: 1261-1266 (1995).

• Emond JC, Whitington PF. Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease). J. Pediatr. Surg. 30: 1635-1641 (1995).

• Endo M, Masuyama H, Watanabe K, Hagane K, Ikawa H, Yokoyama J, Kitajima M. Calculation of biliary atresia prognostic index using a multivariate linear model. J. Pediatr. Surg. 30: 1575-1579 (1995).

• Endresen MJ. The role of fatty acids in gene regulation. An example of an important nutritional factor which may influence our genes. Tidsskr. Nor. Laegeforen. 115: 2084-2086 (1995).

• Engle MJ, Mahmood A, Alpers DH. Two rat intestinal alkaline phosphatase isoforms with different carboxyl-terminal peptides are both membrane-bound by a glycan phosphatidylinositol linkage. J. Biol. Chem. 270: 11935-11940 (1995). *

• Engstrand L. Mycobacterium paratuberculosis and Crohn's disease. Scand. J. Infect. Dis. Suppl. 98: 27-29 (1995).

• Eoli M, Pandolfo M, Amoroso A, Salmaggi A, Zaffaroni M, Gasparini P, DiDonato S, Milanese C, Zeviani M. Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families. Eur. J. Hum. Genet. 3: 303-311 (1995).

• Erasmus DL, Victor TC, van Eeden PJ, Falck V, van Helden P. Mycobacterium paratuberculosis and Crohn's disease. Gut 36: 942 (1995). *

• Eustace S, Buff B, Kane R, Jenkins R, Longmaid HE. The prevalence and clinical significance of lymphadenopathy in primary biliary cirrhosis. Clin. Radiol. 50: 396-399 (1995).

• Evans TI, Han J, Singh R, Moxley G. The genotypic distribution of shared-epitope DRB1 alleles suggests a recessive mode of inheritance of the rheumatoid arthritis disease-susceptibility gene. Arthritis Rheum. 38: 1754-1761 (1995).

• Evoli A, Batocchi AP, Zelano G, Uncini A, Palmisani MT, Tonali P. Familial autoimmune myasthenia gravis: report of four families. J. Neurol. Neurosurg. Psychiatry 58: 729-731 (1995).

• Fan C, Nylander PO, Sikstrom C, Thunell M. Orosomucoid and haptoglobin types in patients with sarcoidosis. Exp. Clin. Immunogenet. 12: 31-35 (1995).

• Farges O, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 117: 146-155 (1995).

• Farmer JA, Gotto AM Jr. Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin. Endocrinol. Metab. 9: 825-847 (1995).

• Farrell DJ, Hines JE, Walls AF, Kelly PJ, Bennett MK, Burt AD. Intrahepatic mast cells in chronic liver diseases. Hepatology 22: 1175-1181 (1995).

• Farstad IN, Halstensen TS, Lazarovits AI, Norstein J, Fausa O, Brandtzaeg P. Human intestinal B-cell blasts and plasma cells express the mucosal homing receptor integrin alpha 4 beta 7. Scand. J. Immunol. 42: 662-672 (1995).

• Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N. Engl. J. Med. 332: 292-297 (1995). *

• Ferguson A. Mechanisms in adverse reactions to food. The gastrointestinal tract. Allergy 50: S32-S38 (1995).

• Fermo I, Vigano' D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann. Intern. Med. 123: 747-753 (1995). *

• Fernandez E, Galan AI, Moran D, Gonzalez-Buitrago JM, Munoz ME, Jimenez R. Reversal of cyclosporine A-induced alterations in biliary secretion by S-adenosyl-L-methionine in rats. J. Pharmacol. Exp. Ther. 275: 442-449 (1995).

• Fernandez-Arquero M, Figueredo MA, Maluenda C, de la Concha EG. HLA-linked genes acting as additive susceptibility factors in celiac disease. Hum. Immunol. 42: 295-300 (1995).

• Ferrell LD, Lee R, Brixko C, Bass NM, Lake JR, Roberts JP, Ascher N, Rabkin J. Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients. Transplantation 60: 926-933 (1995).

• Finnie IA, Dwarakanath AD, Taylor BA, Rhodes JM. Colonic mucin synthesis is increased by sodium butyrate. Gut 36: 93-99 (1995). *

• Fiore M, Pera C, Delfino L, Scotese I, Ferrara GB, Pignata C. DNA typing of DQ and DR alleles in IgA-deficient subjects. Eur. J. Immunogenet. 22: 403-411 (1995).

• Fisher A, Theise ND, Min A, Mor E, Emre S, Pearl A, Schwartz ME, Miller CM, Sheiner PA. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation. Liver Transpl. Surg. 1: 94-98 (1995).

• Floreani A, Marchiori M, Bonato S, Zucchetto M, Naccarato R, Chiaramonte M. Cognitive assessment in primary biliary cirrhosis: a case-control study. Am. J. Gastroenterol. 90: 250-253 (1995).

• Florin TH, Woods HJ. Inhibition of methanogenesis by human bile. Gut 37: 418-421 (1995). *

• Fox RI. Sjogren's syndrome. Curr. Opin. Rheumatol. 7: 409-416 (1995).

• Fracchia M, Soubrane O, Houssin D, Galatola G. Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture. Ital. J. Gastroenterol. 27: 430-435 (1995).

• Frey N, Christen U, Jeno P, Yeaman SJ, Shimomura Y, Kenna JG, Gandolfi AJ, Ranek L, Gut J. The lipoic acid containing components of the 2-oxoacid dehydrogenase complexes mimic trifluoroacetylated proteins and are autoantigens associated with halothane hepatitis. Chem. Res. Toxicol. 8: 736-746 (1995).

• Friedrich C. More on primary biliary cirrhosis in monozygotic twins. N. Engl. J. Med. 332: 336 (1995).

• Frisoni M, Corazza GR, Lafiandra D, De Ambrogio E, Filipponi C, Bonvicini F, Borasio E, Porceddu E, Gasbarrini G. Wheat deficient in gliadins: promising tool for treatment of coeliac disease. Gut 36: 375-378 (1995). *

• Frizzell RA. Functions of the cystic fibrosis transmembrane conductance regulator protein. Am. J. Respir. Crit. Care Med. 151: S54-S58 (1995).

• Fry L. Dermatitis herpetiformis. Baillieres Clin. Gastroenterol. 9: 371-393 (1995).

• Fujimoto M, Sato S, Ihn H, Kikuchi K, Tamaki K, Takehara K. Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Possible role of anti-E1 alpha antibody as a serologic indicator for development of primary biliary cirrhosis. Arthritis Rheum. 38: 985-989 (1995).

• Fujisawa H, Nishimura T, Inaba M, Ikehara S. Suppressive effect of actarit on IgA production in mice: activation of CD4+ suppressor T-cells in Peyer's patches. Int. J. Immunopharmacol. 17: 611-617 (1995).

• Fujita S, Arii S, Monden K, Adachi Y, Funaki N, Higashitsuji H, Furutani M, Mise M, Ishiguro S, Kitao T, et al. Participation of hepatic macrophages and plasma factors in endotoxin-induced liver injury. J. Surg. Res. 59: 263-270 (1995). *

• Fukushima N, Nakamura M, Matsui M, Ikematsu H, Koike K, Ishibashi H, Hayashida K, Niho Y. Establishment and structural analysis of human mAb to the E2 component of the 2-oxoglutarate dehydrogenase complex generated from a patient with primary biliary cirrhosis. Int. Immunol. 7: 1047-1055 (1995).

• Fulmer SB, Schwiebert EM, Morales MM, Guggino WB, Cutting GR. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. Proc. Natl. Acad. Sci. U.S.A. 92: 6832-6836 (1995). *

• Funakoshi K, Sugimura K, Sasakawa T, Bannai H, Anezaki K, Ishizuka K, Yoshida K, Narisawa R, Asakura H. Study of cytokines in ulcerative colitis. J. Gastroenterol. 30 Suppl. 8: 61-63 (1995).

• Furuya T, Tateishi M, Nishinarita M, Kashiwazaki S. Primary biliary cirrhosis in patients with Sjogren's syndrome. Nippon Rinsho 53: 2536-2539 (1995).

• Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, Ohmoto A, Okano H, Miyamoto M, Inaba H. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig. Dis. Sci. 40: 814-818 (1995).

• Gaglia P, Atkin WS, Whitelaw S, Talbot IC, Williams CB, Northover JM, Hodgson SV. Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer. Gut 36: 385-390 (1995). *

• Galbraith GM, Pandey JP. Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum. Genet. 96: 433-436 (1995).

• Gallai V, Sarchielli P, Trequattrini A, Franceschini M, Floridi A, Firenze C, Alberti A, Di Benedetto D, Stragliotto E. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J. Neuroimmunol. 56: 143-153 (1995).

• Gant TW, O'Connor CK, Corbitt R, Thorgeirsson U, Thorgeirsson SS. In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. Toxicol. Appl. Pharmacol. 133: 269-276 (1995). *

• Garcia-Diaz M, Nevado L, Berenguer A, Bureo JC, Bureo P, Saenz de Santamaria J. Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease. Gastroenterol. Hepatol. 18: 18-21 (1995).

• Gardiner KR, Anderson NH, Rowlands BJ, Barbul A. Colitis and colonic mucosal barrier dysfunction. Gut 37: 530-535 (1995). *

• Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 36: 897-901 (1995). *

• Gardiner KR, Maxwell RJ, Rowlands BJ, Barclay GR. Intestinal permeability. Gut 37: 589 (1995). *

• Gendler SJ, Spicer AP. Epithelial mucin genes. Annu. Rev. Physiol. 57: 607-634 (1995). *

• Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect. Control Hosp. Epidemiol. 16: 459-477 (1995).

• Gershwin ME, Mackay IR. New knowledge in primary biliary cirrhosis. Hosp. Pract. (Off. Ed.) 30: 29-36 (1995).

• Ghabanbasani MZ, Gu XX, Spaepen M, Vandevyver C, Raus J, Marynen P, Carton H, Cassiman JJ. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis. J. Neuroimmunol. 59: 77-82 (1995).

• Ghosh AK, Mullins JI. cDNA encoding a functional feline liver/bone/kidney-type alkaline phosphatase. Arch. Biochem. Biophys. 322: 240-249 (1995). *

• Gibson P, Rosella O. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 37: 536-543 (1995). *

• Gibson P, Rosella O, Nov R, Young G. Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer. Gut 36: 857-863 (1995). *

• Gilbrud B, Weiss P, Bakimer R, Shoenfeld Y. Identification and characterization of antimitochondrial autoantibodies in sera of patients with monoclonal gammopathies. Immunol. Lett. 45: 163-166 (1995).

• Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 36: 437-441 (1995). *

• Ginanni Corradini S, Arancia G, Calcabrini A, Della Guardia P, Baiocchi L, Nistri A, Giacomelli L, Angelico M. Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae. J. Hepatol. 22 :642-657 (1995). *

• Gleeson M, Cripps AW, Clancy RL. Modifiers of the human mucosal immune system. Immunol. Cell Biol. 73: 397-404 (1995). *

• Gleeson M, Cripps AW, Clancy RL, Hensley MJ, Henry RJ, Wlodarczyk JH. The significance of transient mucosal IgA deficiency on the development of asthma and atopy in children. Adv. Exp. Med. Biol. 371B: 861-864 (1995).

• Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 37: 668-673 (1995). *

• Gollob JA, Li J, Reinherz EL, Ritz J. CD2 regulates responsiveness of activated T cells to interleukin 12. J. Exp. Med. 182: 721-731 (1995). *

• Goncalves I, Hermans D, Chretien D, Rustin P, Munnich A, Saudubray JM, Van Hoof F, Reding R, de Ville de Goyet J, Otte JB, et al. Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J. Hepatol. 23: 290-294 (1995). *

• Gonzalez FJ, Fernandez-Salguero P, Lee SS, Pineau T, Ward JM. Xenobiotic receptor knockout mice. Toxicol. Lett. 82-83: 117-121 (1995).

• Gonzalez U, Reyes E, Kershenovich J, Orozco-Topete RL. Hypersensitivity syndrome caused by allopurinol. A case of massive hepatic necrosis. Rev. Invest. Clin. 47: 409-413 (1995).

• Goodman ZD, McNally PR, Davis DR, Ishak KG. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig. Dis. Sci. 40: 1232-1242 (1995).

• Gordeladze AS, Smirnov OA, Radchenko VG, Saburova GS. Clinico-morphologic characteristics of primary hemochromatosis. Arkh. Patol. 57: 44-48 (1995).

• Gordon SC, Quattrociocchi-Longe TM, Khan BA, Kodali VP, Chen J, Silverman AL, Kiechle FL. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 108: 1802-1809 (1995). *

• Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harris JP. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere's disease. Laryngoscope 105: 1347-1352 (1995).

• Gran JT, Husby G. HLA-B27 and spondyloarthropathy: value for early diagnosis? J. Med. Genet. 32: 497-501 (1995). *

• Grassi M, Raffa S, Damiani VC, Fontana M. Current orientation in medical management of ulcerative colitis. Clin. Ter. 146: 327-341 (1995).

• Gray MA, Winpenny JP, Verdon B, McAlroy H, Argent BE. Chloride channels and cystic fibrosis of the pancreas. Biosci. Rep. 15: 531-541 (1995).

• Green S. PPAR: a mediator of peroxisome proliferator action. Mutat. Res. 333: 101-109 (1995).

• Greenstein RJ, Greenstein AJ. Is there clinical, epidemiological and molecular evidence for two forms of Crohn's disease? Mol. Med. Today. 1: 343-348 (1995).

• Greenwald P, Kelloff GJ, Boone CW, McDonald SS. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol. Biomarkers Prev. 4: 691-702 (1995). *

• Gregorio GV, Davies ET, Mieli-Vergani G, Vergani D. Significance of extractable nuclear antigens in childhood autoimmune liver disease. Clin. Exp. Immunol. 102: 308-313 (1995). *

• Grimm MC, Pavli P, Van de Pol E, Doe WF. Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis. Clin. Exp. Immunol. 100: 291-297 (1995). *

• Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J. Gastroenterol. Hepatol. 10: 387-395 (1995).

• Grinko I, Geerts A, Wisse E. Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia. J. Hepatol. 23: 449-458 (1995). *

• Groen AK, Van Wijland MJ, Frederiks WM, Smit JJ, Schinkel AH, Oude Elferink RP. Regulation of protein secretion into bile: studies in mice with a disrupted mdr2 p-glycoprotein gene. Gastroenterology 109: 1997-2006 (1995). *

• Gross K, Combe C, Kruger K, Schattenkirchner M. Arthritis after hepatitis B vaccination. Report of three cases. Scand. J. Rheumatol. 24: 50-52 (1995).

• Gross WL. Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum. Dis. Clin. North Am. 21: 987-1011 (1995).

• Gross WL, Csernok E, Helmchen U. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis. APMIS 103: 81-97 (1995).

• Grubb BR. Ion transport across the jejunum in normal and cystic fibrosis mice. Am. J. Physiol. 268: G505-G513 (1995). *

• Grubic Z, Zunec R, Naipal A, Kastelan A, Giphart MJ. Molecular analysis of HLA class II polymorphism in Croatians. Tissue Antigens 46: 293-298 (1995).

• Grubman SA, Fang SL, Mulberg AE, Perrone RD, Rogers LC, Lee DW, Armentano D, Murray SL, Dorkin HL, Cheng SH, et al. Correction of the cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell lines. Gastroenterology 108: 584-592 (1995). *

• Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181: 1133-1144 (1995). *

• Gumperz JE, Parham P. The enigma of the natural killer cell. Nature 378: 245-248 (1995). *

• Guo K, Major G, Foster H, Bassendine M, Collier J, Ross D, Griffiths I. Defective repair of O6-methylguanine-DNA in primary Sjogren's syndrome patients predisposed to lymphoma. Ann. Rheum. Dis. 54: 229-232 (1995). *

• Guo X, Zhang YP, Mitchell DA, Denhardt DT, Chambers AF. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol. Cell. Biol. 15: 476-487 (1995). *

• Gur H, Shen G, Sutjita M, Terrberry J, Alosachie I, Barka N, Lin HC, Peter JB, Meroni PL, Kaplan M, et al. Autoantibody profile of primary sclerosing cholangitis. Pathobiology 63: 76-82 (1995).

• Gurbuz AK, Giardiello FM, Bayless TM. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis. Colon Rectum 38: 37-41 (1995). *

• Gustchina A, Zdanov A, Schalk-Hihi C, Wlodawer A. A model of the complex between interleukin-4 and its receptors. Proteins 21: 140-148 (1995).

• Gut J, Christen U, Frey N, Koch V, Stoffler D. Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens. Toxicology 97: 199-224 (1995).

• Gylling H, Farkkila M, Vuoristo M, Miettinen TA. Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics. Hepatology 21: 89-95 (1995).

• Haahr S, Koch-Henriksen N, Moller-Larsen A, Eriksen LS, Andersen HM. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Mult. Scler. 1: 73-77 (1995).

• Hacsek G, Arato A, Savilahti E, Paszti I. Characteristics of HLA II antigen expression in the rectal mucosa of children suffering from ulcerative colitis and Crohn disease. Orv. Hetil. 136: 2279-2282 (1995).

• Hadziselimovic F, Emmons LR, Gallati H. Soluble tumour necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease. Gut 37: 260-263 (1995). *

• Haggett PJ, Moore NR, Shearman JD, Travis SP, Jewell DP, Mortensen NJ. Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging. Gut 36: 407-410 (1995). *

• Halstensen TS, Das KM, Brandtzaeg P. Epithelial deposits of immunoglobulin G1 and activated complement co-localize with the "M(r) 40kD" putative auto-antigen in ulcerative colitis. Adv. Exp. Med. Biol. 371B: 1273-1276 (1995).

• Hamadeh RM, Galili U, Zhou P, Griffiss JM. Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. Clin. Diagn. Lab. Immunol. 2: 125-131 (1995).

• Hamilton MI, Bradley NJ, Srai SK, Thrasivoulou C, Pounder RE, Wakefield AJ. Autoimmunity in ulcerative colitis: tropomyosin is not the major antigenic determinant of the Das monoclonal antibody, 7E12H12. Clin. Exp. Immunol. 99: 404-411 (1995). *

• Hammer RE, Richardson JA, Simmons WA, White AL, Breban M, Taurog JD. High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease. J. Investig. Med. 43: 262-268 (1995).

• Hamza M, Makni S. Secretory component deficiency in Behcet's disease. Clin. Rheumatol. 14: 227-228 (1995).

• Han S, Tredger M, Gregorio GV, Mieli-Vergani G, Vergani D. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology 21: 58-62 (1995).

• Harada H, Miki R, Masushige S, Kato S. Gene expression of retinoic acid receptors, retinoid-X receptors, and cellular retinol-binding protein I in bone and its regulation by vitamin A. Endocrinology 136: 5329-5335 (1995).

• Harmon MA, Boehm MF, Heyman RA, Mangelsdorf DJ. Activation of mammalian retinoid X receptors by the insect growth regulator methoprene. Proc. Natl. Acad. Sci. U.S.A. 92: 6157-6160 (1995). *

• Hart AR, Wicks AC, Mayberry JF. Colorectal cancer screening in asymptomatic populations. Gut 36: 590-598 (1995). *

• Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin. Exp. Immunol. 99: 331-337 (1995). *

• Hassan T, Kanisawa Y, Meyers S, Dasgupta A, Das KM. Expression of a unique protein on colon cancer cells that reacts with a novel monoclonal antibody and ulcerative colitis serum. Clin. Exp. Immunol. 100: 457-462 (1995). *

• Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone 17: 33S-38S (1995).

• Hautekeete ML. Hepatotoxicity of antibiotics. Acta Gastroenterol. Belg. 58: 290-296 (1995).

• Hautekeete ML, Brenard R, Horsmans Y, Henrion J, Verbist L, Derue G, Druez P, Omar M, Kockx M, Hubens H, et al. Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. J. Hepatol. 22: 71-77 (1995). *

• Hautekeete ML, Henrion J, Naegels S, DeNeve A, Adler M, Deprez C, Devis G, Kloppel G. Severe hepatotoxicity related to benzarone: a report of three cases with two fatalities. Liver 15: 25-29 (1995).

• Hautekeete ML, Kockx MM, Naegels S, Holvoet JK, Hubens H, Kloppel G. Cholestatic hepatitis related to quinolones: a report of two cases. J. Hepatol. 23: 759-760 (1995). *

• Hay JE. Bone disease in cholestatic liver disease. Gastroenterology 108: 276-283 (1995). *

• Hayashi Y, Hamano H, Haneji N, Ishimaru N, Yanagi K. Biased T cell receptor V beta gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjogren's syndrome. Arthritis Rheum. 38: 1077-1084 (1995).

• Heathcote J, Wanless IR. Hepatotoxicity: newer aspects of pathogenesis and treatment. Gastroenterologist 3: 119-129 (1995).

• Hebuterne X, Wang XD, Johnson EJ, Krinsky NI, Russell RM. Intestinal absorption and metabolism of 9-cis-beta-carotene in vivo: biosynthesis of 9-cis-retinoic acid. J. Lipid Res. 36: 1264-1273 (1995). *

• Hedges SR, Agace WW, Svanborg C. Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol. 3: 266-270 (1995). *

• Henriksen AZ, Maeland JA. Immunogenicity expressed in patients with bacteraemia of an epitope shared by enterobacterial and neisserial porin proteins. APMIS 103: 388-394 (1995).

• Henz S, Buhler H, Pirovino M. Spontaneous bacterial peritonitis: diagnostic and prognostic aspects. Schweiz. Med. Wochenschr. 125: 2379-2386 (1995).

• Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson A. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand. J. Gastroenterol. 30: 693-698 (1995).

• Hewett SJ, Choi DW, Gutmann DH. Expression of the neurofibromatosis 1 (NF1) gene in reactive astrocytes in vitro. Neuroreport 6: 1565-1568 (1995).

• Hildebrandt R, Gundert-Remy U, Raedsch R, Sieg A, Stiehl A. Biliary excretion of mezlocillin in patients with hepatic disease. Int. J. Clin. Pharmacol. Ther. 33: 384-387 (1995).

• Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture. Hepatology 22: 82-87 (1995).

• Hillingso J, Kjeldsen J, Laursen LS, Lauritsen K, von Spreckelsen S, Depre M, Friedman BS, Malmstrom K, Shingo S, Bukhave K, et al. Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis. Clin. Pharmacol. Ther. 57: 335-341 (1995).

• Hilzenrat N, Spanier A, Lamoureux E, Bloom C, Sherker A. Colonic obstruction secondary to sarcoidosis: nonsurgical diagnosis and management. Gastroenterology 108: 1556-1559 (1995). *

• Hirano F, Tanaka H, Makino Y, Okamoto K, Inaba M, Miura T, Makino I. Regulation of the major histocompatibility complex class I mRNA expression by bile acids in cultured human hepatoma cells. Biochem. Biophys. Res. Commun. 208: 935-942 (1995). *

• Hirasawa A, Sato T, Nishikawa T, Uozumi K, Wakabayashi Y, Takeuchi K, Chiba S. An adult diagnosed as hyper-IgM immunodeficiency syndrome. Intern. Med. 34: 640-642 (1995). *

• Hofmann AF. Bile acids as drugs: principles, mechanisms of action and formulations. Ital. J. Gastroenterol. 27: 106-113 (1995).

• Hofmann AF. Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions. J. Pediatr. Gastroenterol. Nutr. 20: 376-390 (1995).

• Holtkamp W, Stollberg T, Reis HE. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J. Clin. Gastroenterol. 20: 123-126 (1995).

• Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1: 576-582 (1995). *

• Horst RL, Reinhardt TA, Goff JP, Nonnecke BJ, Gambhir VK, Fiorella PD, Napoli JL. Identification of 9-cis,13-cis-retinoic acid as a major circulating retinoid in plasma. Biochemistry 34: 1203-1209 (1995).

• Horwitz AH, Williams RE, Nowakowski G. Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein. Infect. Immun. 63: 522-527 (1995). *

• Houwen RH, Juyn J, Hoogenraad TU, Ploos van Amstel JK, Berger R. H714Q mutation in Wilson disease is associated with late, neurological presentation. J. Med. Genet. 32: 480-482 (1995).

• Howell WM, Leung ST, Jones DB, Nakshabendi I, Hall MA, Lanchbury JS, Ciclitira PJ, Wright DH. HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum. Immunol. 43: 29-37 (1995).

• Hsieh JC, Nakajima S, Galligan MA, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR. Receptor mediated genomic action of the 1,25(OH)2D3 hormone: expression of the human vitamin D receptor in E. coli. J. Steroid Biochem. Mol. Biol. 53: 583-594 (1995).

• Hu B, Hissong BD, Carlin JM. Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes. J. Interferon Cytokine Res. 15: 617-624 (1995).

• Huang DF, Siminovitch KA, Liu XY, Olee T, Olsen NJ, Berry C, Carson DA, Chen PP. Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus. J. Clin. Invest. 95: 1766-1772 (1995). *

• Huang HS, Peng JT, She JY, Zhang LP, Chao CC, Liu KH, She JX. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Hum. Immunol. 44: 210-219 (1995).

• Huang MJ, Liaw YF. Clinical associations between thyroid and liver diseases. J. Gastroenterol. Hepatol. 10: 344-350 (1995).

• Hussaini SH, Pereira SP, Murphy GM, Kennedy C, Wass JA, Besser GM, Dowling RH. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid. Gut 36: 126-132 (1995). *

• Hyams JS, Fitzgerald JE, Wyzga N, Muller R, Treem WR, Justinich CJ, Kreutzer DL. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 21: 419-425 (1995).

• Ibbotson JP, Lowes JR. Potential role of superantigen induced activation of cell mediated immune mechanisms in the pathogenesis of Crohn's disease. Gut 36: 1-4 (1995). *

• Ikarashi Y, Matsumoto Y, Omata S, Fujiwara M. Recipient-derived T cells participate in autoimmune-like hepatic lesions induced by graft-versus-host reaction. Autoimmunity 20: 121-127 (1995).

• Ikehata A, Hiwatashi N, Kinouchi Y, Yamazaki H, Ito K, Toyota T. Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease. Scand. J. Gastroenterol. 30: 44-49 (1995).

• Ilyas M, Talbot IC. p53 expression in ulcerative colitis: a longitudinal study. Gut 37: 802-804 (1995). *

• Indraccolo S, Gunzburg WH, Leib-Mosch C, Erfle V, Salmons B. Identification of three human sequences with viral superantigen-specific primers. Mamm. Genome 6: 339-344 (1995).

• Inoue K, Hirohara J, Nakano T, Seki T, Sasaki H, Higuchi K, Ohta Y, Onji M, Muto Y, Moriwaki H. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 15: 70-77 (1995).

• Isoyama K, Yamada K, Ishikawa K, Sanada Y. Coincidental cases of primary sclerosing cholangitis and biliary atresia in siblings? Acta Paediatr. 84: 1444-1446 (1995).

• Ito M, Kojima T, Miyata M, Saka M, Kokubun M, Ohira H, Ishikawa H, Kuroda M, Sato Y, Takagi T, et al. Primary biliary cirrhosis (PBC)-CREST (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly and telangiectasia) overlap syndrome complicated by Sjogren's syndrome and arthritis. Intern. Med. 34: 451-454 (1995). *

• Jaaskelainen T, Itkonen A, Maenpaa PH. Retinoid-X-receptor-alpha-independent binding of vitamin D receptor to its response element from human osteocalcin gene. Eur. J. Biochem. 228: 222-228 (1995).

• Jackson LD, Song E. Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis. Gut 36: 459-461 (1995). *

• Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J. Hepatol. 23: 123-128 (1995). *

• Jalan R, Gooday R, O'Carroll RE, Redhead DN, Elton RA, Hayes PC. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. J. Hepatol. 23: 697-705 (1995). *

• Janczewska I, Ericzon BG, Eriksson LS. Influence of orthotopic liver transplantation on serum vitamin A levels in patients with chronic liver disease. Scand. J. Gastroenterol. 30: 68-71 (1995).

• Jaspan JB, Luo H, Ahmed B, Tenenbaum S, Voss T, Sander DM, Bollinger K, Baquet T, Garry RF. Evidence for a retroviral trigger in Graves' disease. Autoimmunity 20: 135-142 (1995).

• Javitt NB. Cholesterol homeostasis: role of the LDL receptor. FASEB J. 9: 1378-1381 (1995). *

• Jenkins AP, el-Omar MM, Booth JC, Banerjee AK, Burnand KG, Thompson RP. Recurrent gastrointestinal bleeding associated with chronic pancreatitis. Gut 36: 314-316 (1995). *

• Jennette JC, Falk RJ, Wilkman AS. Anti-neutrophil cytoplasmic autoantibodies - a serologic marker for vasculitides. Ann. Acad. Med. Singapore 24: 248-253 (1995).

• Jewell DP. Pathogenesis of Crohn's disease: the environment revisited. Eur. J. Gastroenterol. Hepatol. 7: 383-384 (1995).

• Jones BB, Ohno CK, Allenby G, Boffa MB, Levin AA, Grippo JF, Petkovich M. New retinoid X receptor subtypes in zebra fish (Danio rerio) differentially modulate transcription and do not bind 9-cis retinoic acid. Mol. Cell. Biol. 15: 5226-5234 (1995). *

• Jones DE, James OF, Bassendine MF. Ursodeoxycholic acid therapy in primary biliary cirrhosis. Hepatology 21: 1469-1473 (1995).

• Jones DE, Palmer JM, James OF, Yeaman SJ, Bassendine MF, Diamond AG. T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 21: 995-1002 (1995).

• Jones SC, Banks RE, Haidar A, Gearing AJ, Hemingway IK, Ibbotson SH, Dixon MF, Axon AT. Adhesion molecules in inflammatory bowel disease. Gut 36: 724-730 (1995). *

• Joplin R, Wallace LL, Johnson GD, Lindsay JG, Yeaman SJ, Palmer JM, Strain AJ, Neuberger JM. Subcellular localization of pyruvate dehydrogenase dihydrolipoamide acetyltransferase in human intrahepatic biliary epithelial cells. J. Pathol. 176: 381-390 (1995).

• Jorgensen RA, Dickson ER, Hofmann AF, Rossi SS, Lindor KD. Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut 36: 935-938 (1995). *

• Jorgensen RA, Lindor KD, Sartin JS, LaRusso NF, Wiesner RH. Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis. J. Clin. Gastroenterol. 20: 215-219 (1995).

• Juge-Aubry CE, Gorla-Bajszczak A, Pernin A, Lemberger T, Wahli W, Burger AG, Meier CA. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat. J. Biol. Chem. 270: 18117-18122 (1995). *

• Kadunce DP, Krueger GG. Pathogenesis of psoriasis. Dermatol. Clin. 13: 723-737 (1995).

• Kagalwalla AF, Al Amir AR, Khalifa A, Sylven M, Al Ajaji S, Kagalwalla YA. Progressive familial intrahepatic cholestasis (Byler's disease) in Arab children. Ann. Trop. Paediatr. 15: 321-327 (1995).

• Kain R, Matsui K, Exner M, Binder S, Schaffner G, Sommer EM, Kerjaschki D. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial … J. Exp. Med. 181: 585-597 (1995). *

• Kakei N, Miki K. Liver dysfunction in patients with inflammatory bowel disease - with special reference to primary sclerosing cholangitis. Ryoikibetsu Shokogun Shirizu 8: 301-304 (1995).

• Kallenberg CG, Brouwer E, Mulder AH, Stegeman CA, Weening JJ, Tervaert JW. ANCA - pathophysiology revisited. Clin. Exp. Immunol. 100: 1-3 (1995). *

• Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 36: 146-147 (1995). *

• Kane KF, Langman MJ, Williams GR. 1,25-Dihydroxyvitamin D3 and retinoid X receptor expression in human colorectal neoplasms. Gut 36: 255-258 (1995). *

• Kaneko K, Suzuki Y, Shimizu T, Yamashiro Y, Yabuta K, Lifschitz CH. Anti-neutrophil cytoplasmic antibodies in Japanese children with ulcerative colitis. J. Paediatr. Child. Health 31: 336-338 (1995).

• Kapur KC, Williams GT, Allison MC. Mesalazine induced exacerbation of ulcerative colitis. Gut 37: 838-839 (1995). *

• Karanikas V, MacKay IR, Rowley MJ, Veitch B, Loveland BE. Hepatic portal infiltrates in mice immunized with syngeneic lymphoid cells: connotations for models of autoimmune liver disease. J. Gastroenterol. Hepatol. 10: 491-497 (1995).

• Karmeli F, Eliakim R, Okon E, Samuni A, Rachmilewitz D. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. Gut 37: 386-393 (1995). *

• Kaw M, Silverman WB, Rabinovitz M, Schade RR. Biliary tract calculi in primary sclerosing cholangitis. Am. J. Gastroenterol. 90: 72-75 (1995).

• Kawahito Y, Sano H, Mukai S, Asai K, Kimura S, Yamamura Y, Kato H, Chrousos GP, Wilder RL, Kondo M. Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 37: 544-551 (1995). *

• Kay RA. The potential role of superantigens in inflammatory bowel disease. Clin. Exp. Immunol. 100: 4-6 (1995). *

• Kazi N, Fields JZ, Sedghi S, Kottapalli V, Eiznhamer D, Winship D, Keshavarzian A. Modulation of neutrophil function by novel colonic factors: possible role in the pathophysiology of ulcerative colitis. J. Lab. Clin. Med. 126: 70-80 (1995).

• Kazuta Y, Watanabe N, Sagawa K, Kobayashi H, Kojima T, Funabashi H, Moritoh T, Kasukawa R. A case of autoimmune hemolytic anemia induced by IFN-beta therapy for type-C chronic hepatitis. Fukushima J. Med. Sci. 41: 43-49 (1995).

• Keicher U, Koletzko B, Reinhardt D. Omega-3 fatty acids suppress the enhanced production of 5-lipoxygenase products from polymorph neutrophil granulocytes in cystic fibrosis. Eur. J. Clin. Invest. 25: 915-919 (1995).

• Kerem E, Kalman YM, Yahav Y, Shoshani T, Abeliovich D, Szeinberg A, Rivlin J, Blau H, Tal A, Ben-Tur L, et al. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum. Genet. 96: 193-197 (1995).

• Kerr JR, Cartron JP, Curran MD, Moore JE, Elliott JR, Mollan RA. A study of the role of parvovirus B19 in rheumatoid arthritis. Br. J. Rheumatol. 34: 809-813 (1995).

• Kersten S, Kelleher D, Chambon P, Gronemeyer H, Noy N. Retinoid X receptor alpha forms tetramers in solution. Proc. Natl. Acad. Sci. U.S.A. 92: 8645-8649 (1995). *

• Kersten S, Pan L, Chambon P, Gronemeyer H, Noy N. Role of ligand in retinoid signaling. 9-cis-retinoic acid modulates the oligomeric state of the retinoid X receptor. Biochemistry 34: 13717-13721 (1995).

• Kersten S, Pan L, Noy N. On the role of ligand in retinoid signaling: positive cooperativity in the interactions of 9-cis retinoic acid with tetramers of the retinoid X receptor. Biochemistry 34: 14263-14269 (1995).

• Kett K, Baklien K, Bakken A, Kral JG, Fausa O, Brandtzaeg P. Intestinal B-cell isotype response in relation to local bacterial load: evidence for immunoglobulin A subclass adaptation. Gastroenterology 109: 819-825 (1995).

• Khoo UY, Bjarnason I, Donaghy A, Williams R, Macpherson A. Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis. Gut 37: 63-70 (1995). *

• Ki Hong W, Lippman SM, Hittelman WN, Lotan R. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin. Cancer Res. 1: 677-686 (1995).

• Kikuchi K, Kubo M, Sato S, Fujimoto M, Tamaki K. Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J. Am. Acad. Dermatol. 33: 973-978 (1995).

• Kim HY, Kim TG, Park SH, Lee SH, Cho CS, Han H. Predominance of HLA-DRB1*0405 in Korean patients with rheumatoid arthritis. Ann. Rheum. Dis. 54: 988-990 (1995). *

• Kim WH, Choi PM, Landers CJ, Targan SR. Role of antineutrophil cytoplasmic antibodies in an ethnically distinct population: Korean patients with ulcerative colitis. Am. J. Gastroenterol. 90: 1953-1958 (1995).

• Kimura A, Nakamura K, Makino I. Measurement of bile acid N-acetylglucosaminides in serum and urine of patients with chronic liver diseases during ursodeoxycholic acid treatment. Nippon Shokakibyo Gakkai Zasshi 92: 224-232 (1995).

• Kirman I, Nielsen OH, Kjaersgaard E, Brynskov J. Interleukin-2 receptor alpha and beta chain expression by circulating alpha beta and gamma delta T cells in inflammatory bowel disease. Dig. Dis. Sci. 40: 291-295 (1995).

• Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J. Gastroenterol. 30 Suppl. 8: 5-8 (1995).

• Kitami N, Komada T, Ishii H, Shimizu H, Adachi H, Yamaguchi Y, Kitamura T, Oide H, Miyazaki A, Ishikawa M, et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern. Med. 34: 496-501 (1995). *

• Kjeldsen J, Schaffalitzky de Muckadell OB, Junker P. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut 37: 805-810 (1995). *

• Klemola T, Savilahti E, Arato A, Ormala T, Partanen J, Eland C, Koskimies S. Immunohistochemical findings in jejunal specimens from patients with IgA deficiency. Gut 37: 519-523 (1995). *

• Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83: 813-819 (1995). *

• Klinge O. Intrahepatic cholangitis with presumably immunologic bases. Verh. Dtsch. Ges. Pathol. 79: 198-232 (1995).

• Klotz U. 5-Aminosalicylic acid and chronic inflammatory bowel diseases in children. Klin. Padiatr. 207: 285-287 (1995).

• Knechtle SJ, D'Alessandro AM, Harms BA, Pirsch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 118: 615-619 (1995).

• Knisely AS. Copper associated childhood cirrhosis. Gut 37: 590-591 (1995). *

• Knoerzer DB, Karr RW, Schwartz BD, Mengle-Gaw LJ. Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. J. Clin. Invest. 96: 987-993 (1995). *

• Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J. Hepatol. 22: 226-229 (1995). *

• Kobayashi K, Shibata T, Sugisaki T. Aggravation of rat nephrotoxic serum nephritis by anti-myeloperoxidase antibodies. Kidney Int. 47: 454-463 (1995).

• Koblik PD, Hornof WJ, Yen CK, Fisher PE, Komtebedde J. Use of technetium-99m sulfur colloid to evaluate changes in reticuloendothelial function in dogs with experimentally induced chronic biliary cirrhosis and portosystemic shunting. Am. J. Vet. Res. 56: 688-693 (1995).

• Kochhar DM, Jiang H, Penner JD, Heyman RA. Placental transfer and developmental effects of 9-cis retinoic acid in mice. Teratology 51: 257-265 (1995).

• Koh WH, Dunphy J, Whyte J, Dixey J, McHugh NJ. Characterisation of anticytoplasmic antibodies and their clinical associations. Ann. Rheum. Dis. 54: 269-273 (1995). *

• Kohn FR, Kung AH. Role of endotoxin in acute inflammation induced by Gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein. Infect. Immun. 63: 333-339 (1995). *

• Koj A, Guzdek A, Nakamura T, Kordula T. Hepatocyte growth factor and retinoic acid exert opposite effects on synthesis of type 1 and type 2 acute phase proteins in rat hepatoma cells. Int. J. Biochem. Cell Biol. 27: 39-46 (1995).

• Kojima S, Toyota Y, Shiba M, Tsushima M, Matsuoka H, Yamamoto A. Different apheresis methods in the treatment of hypercholesterolemia in primary biliary cirrhosis: a case report. Artif. Organs 19: 938-941 (1995).

• Kolb E. The significance of vitamin A for the immune system (review). Berl. Munch. Tierarztl. Wochenschr. 108: 385-390 (1995).

• Kolbus N, Beuche W, Schlaf G, Nusslein HG, Felgenhauer K, Mader M. Origin and immunoregulation of autoantibodies against intestinal alkaline phosphatase. Scand. J. Immunol. 41: 414-420 (1995).

• Kontakou M, Przemioslo RT, Sturgess RP, Limb AG, Ciclitira PJ. Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease. Scand. J. Gastroenterol. 30: 456-463 (1995).

• Kontakou M, Przemioslo RT, Sturgess RP, Limb GA, Ellis HJ, Day P, Ciclitira PJ. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. Gut 37: 52-57 (1995). *

• Kosaka K, Yamanobe S, Tomiyama S, Yagi T. Inner ear autoantibodies in patients with sensorineural hearing loss. Acta Otolaryngol. Suppl. 519: 176-177 (1995).

• Kossa K, Coulthart A, Ives CT, Pusey CD, Hodgson HJ. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 7: 783-789 (1995).

• Kraft JC, Kimelman D, Juchau MR. Xenopus laevis: a model system for the study of embryonic retinoid metabolism. I. Embryonic metabolism of 9-cis- and all-trans-retinals and retinols to their corresponding acid forms. Drug Metab. Dispos. 23: 72-82 (1995). *

• Kramer DR, Sutherland RM, Bao S, Husband AJ. Cytokine mediated effects in mucosal immunity. Immunol. Cell Biol. 73: 389-396 (1995). *

• Krause I, Hacham S, Gilburd B, Damianovitch M, Blank M, Shoenfeld Y. Absence of anti-idiotypic antibodies in IVIG preparations to autoantibodies of rare autoimmune diseases. Clin. Immunol. Immunopathol. 77: 229-235 (1995). *

• Kreuzpaintner G, Das PK, Stronkhorst A, Slob AW, Strohmeyer G. Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen in Crohn's disease. Gut 37: 361-366 (1995). *

• Kreuzpaintner G, Kirschner P, Wallner A, Kolble R, Hesterberg R, Thomas L, Borchard F. Mycobacteria of Runyon groups I, II and IV do not play an aetiological role in Crohn's disease. Eur. J. Gastroenterol. Hepatol. 7: 1177-1182 (1995).

• Kroger H, Klewer M, Gratz R, Dietrich A, Ockenfels H, Miesel R. Exacerbation of acetaminophen hepatotoxicity by thalidomide and protection by nicotinic acid amide. Gen. Pharmacol. 26: 1243-1247 (1995). *

• Kruger K. Use of cyclosporin A in chronic polyarthritis and other rheumatic diseases. Z. Rheumatol. 54: 89-95 (1995).

• Kruis W, Judmaier G, Kayasseh L, Stolte M, Theuer D, Scheurlen C, Hentschel E, Kratochvil P. Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 7: 391-396 (1995).

• Kucharzik T, Stoll R, Lugering N, Domschke W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 100: 452-456 (1995). *

• Kuwana M, Okano Y, Kaburaki J, Inoko H. HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma). Ann. Rheum. Dis. 54: 983-987 (1995). *

• Kvale D, Brandtzaeg P. Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29. Gut 36: 737-742 (1995). *

• Labrecque J, Dumas F, Lacroix A, Bhat PV. A novel isoenzyme of aldehyde dehydrogenase specifically involved in the biosynthesis of 9-cis and all-trans retinoic acid. Biochem. J. 305: 681-684 (1995). *

• Lacaille F. Bile acids and their therapeutic use in children. Arch. Pediatr. 2: 1200-1208 (1995).

• Lacaille F, Canioni D, Bernard O, Fabre M, Brousse N, Schmitz J. Celiac disease, inflammatory colitis, and primary sclerosing cholangitis in a girl with Turner's syndrome. J. Pediatr. Gastroenterol. Nutr. 21: 463-467 (1995).

• Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am. J. Gastroenterol. 90: 247-249 (1995).

• Lacour JP, Ortonne JP. Genetics of vitiligo. Ann. Dermatol. Venereol. 122: 167-171 (1995).

• Ladero JM, Benitez J, Serrano M, Garcia-Paredes J, Diaz-Rubio M. Debrisoquine oxidation polymorphism in patients with chronic inflammatory bowel disease. Ann. Med. 27: 555-558 (1995).

• Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11: 241-247 (1995). *

• Lankisch PG, Droge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut 37: 565-567 (1995). *

• Lash LH, Xu Y, Elfarra AA, Duescher RJ, Parker JC. Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab. Dispos. 23: 846-853 (1995).

• Lashner BA. Epidemiology of inflammatory bowel disease. Gastroenterol. Clin. North Am. 24: 467-474 (1995).

• Lashner BA, Provencher KS, Bozdech JM, Brzezinski A. Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. Am. J. Gastroenterol. 90: 377-380 (1995).

• Laurent-Puig P, Lubin R, Semhoun-Ducloux S, Pelletier G, Fourre C, Ducreux M, Briantais MJ, Buffet C, Soussi T. Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases. Gut 36: 455-458 (1995). *

• Lawrence SP, Lezotte DC, Durham JD, Kumpe DA, Everson GT, Bilir BM. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis. Dig. Dis. Sci. 40: 1575-1580 (1995).

• Le Moine O, Soupison T, Sogni P, Marchant A, Moreau R, Hadengue A, Goldman M, Deviere J, Lebrec D. Plasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis. J. Hepatol. 23: 391-395 (1995). *

• Le Thi Huong D, Valla D, Franco D, Wechsler B, De Gramont A, Auperin A, Godeau P. Cholangitis associated with paroxysmal nocturnal hemoglobinuria: another instance of ischemic cholangiopathy? Gastroenterology 109: 1338-1343 (1995).

• Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 55: 165-168 (1995).

• Lee JC, Lennard-Jones JE, Cambridge G. Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 108: 428-433 (1995). *

• Lee JG, Schutz SM, England RE, Leung JW, Cotton PB. Endoscopic therapy of sclerosing cholangitis. Hepatology 21: 661-667 (1995).

• Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-Myb expression. J. Clin. Invest. 96: 2461-2468 (1995). *

• Lee MO, Liu Y, Zhang XK. A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene. Mol. Cell. Biol. 15: 4194-4207 (1995). *

• Lee YM, Kaplan MM. Primary sclerosing cholangitis. N. Engl. J. Med. 332: 924-933 (1995). *

• Leelayuwat C, Pinelli M, Dawkins RL. Clustering of diverse replicated sequences in the MHC. Evidence for en bloc duplication. J. Immunol. 155: 692-698 (1995).

• Lefort A, Dachary D, Vergier B, Boiron G. Lichen planus and vaccination against hepatitis B. Ann. Dermatol. Venereol. 122: 701-703 (1995).

• Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270: 12953-12956 (1995). *

• Leibovitch L, George J, Levi Y, Bakimer R, Shoenfeld Y. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA. Immunol. Lett. 48: 129-132 (1995).

• Leidenius MH, Koskimies SA, Kellokumpu IH, Hockerstedt KA. HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 103: 519-524 (1995).

• Lenzi M, Manotti P, Muratori L, Cataleta M, Ballardini G, Cassani F, Bianchi FB. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut 36: 749-754 (1995). *

• Leo MA, Ahmed S, Aleynik SI, Siegel JH, Kasmin F, Lieber CS. Carotenoids and tocopherols in various hepatobiliary conditions. J. Hepatol. 23: 550-556 (1995). *

• Leon MP, Kirby JA, Gibbs P, Burt AD, Bassendine MF. Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J. Hepatol. 22: 591-595 (1995). *

• Leon MP, Spickett G, Jones DE, Bassendine MF. CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin. Exp. Immunol. 99: 233-239 (1995). *

• Leonard N, Hourihane DO, Whelan A. Neuroproliferation in the mucosa is a feature of coeliac disease and Crohn's disease. Gut 37: 763-765 (1995). *

• Lerut J, Golder S, Mahler F. Improvement of Raynaud's phenomenon after liver transplantation for end-stage primary biliary cirrhosis. Hepatogastroenterology 42: 209-211 (1995).

• Leung DY, Travers JB, Norris DA. The role of superantigens in skin disease. J. Invest. Dermatol. 105: 37S-42S (1995).

• Leung PS, Chuang DT, Wynn RM, Cha S, Danner DJ, Ansari A, Coppel RL, Gershwin ME. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 22: 505-513 (1995).

• Leuschner U, Guldutuna S, Bhatti S, Elze A, Imhof M, You T, Zimmer G. TUDCA and UDCA are incorporated into hepatocyte membranes: different sites, but similar effects. Ital. J. Gastroenterol. 27: 376-377 (1995).

• Levine JB, Lukawski-Trubish D. Extraintestinal considerations in inflammatory bowel disease. Gastroenterol. Clin. North Am. 24: 633-646 (1995).

• Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins. J. Immunol. 154: 5403-5410 (1995).

• Lichtman SN, Wang J, Clark RL. A microcholangiographic study of liver disease models in rats. Acad. Radiol. 2: 515-521 (1995).

• Lilja I, Smedh K, Olaison G, Sjodahl R, Tagesson C, Gustafson-Svard C. Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis. Gut 37: 380-385 (1995). *

• Lim AG, Jazrawi RP, Levy JH, Petroni ML, Douds AC, Maxwell JD, Northfield TC. Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J. Hepatol. 22: 416-422 (1995). *

• Lim AG, Jazrawi RP, Northfield TC. The ursodeoxycholic acid story in primary biliary cirrhosis. Gut 37: 301-304 (1995). *

• Lin TT, Yeh CT, Wu CS, Liaw YF. Detection and partial sequence analysis of Helicobacter pylori DNA in the bile samples. Dig. Dis. Sci. 40: 2214-2219 (1995).

• Lindberg E, Soderholm JD, Olaison G, Tysk C, Jarnerot G. Intestinal permeability to polyethylene glycols in monozygotic twins with Crohn's disease. Scand. J. Gastroenterol. 30: 780-783 (1995).

• Lindgren S, Floren CH, Lindhagen T, Starck M, Stewenius J, Nassberger L. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Eur. J. Gastroenterol. Hepatol. 7: 563-568 (1995).

• Lindor KD. Colchicine and ursodeoxycholic acid for primary biliary cirrhosis: emerging results. Gastroenterology 108: 1592-1594 (1995).

• Lindor KD. Primary biliary cirrhosis. Rev. Gastroenterol. Mex. 60 (4 Suppl. 2): S75-S77 (1995).

• Lindor KD. Primary sclerosing cholangitis. Rev. Gastroenterol. Mex. 60 (4 Suppl. 2): S78-S80 (1995).

• Lindor KD, Dickson ER, Jorgensen RA, Anderson ML, Wiesner RH, Gores GJ, Lange SM, Rossi SS, Hofmann AF, Baldus WP. The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study. Hepatology 22: 1158-1162 (1995).

• Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER. Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 21: 389-392 (1995).

• Linn SC, Giaccone G. MDR1/P-glycoprotein expression in colorectal cancer. Eur. J. Cancer 31A: 1291-1294 (1995).

• Linsley PS. The CD28/CTLA-4:B7 receptor system in experimental autoimmune encephalomyelitis. J. Clin. Invest. 95: 2429-2430 (1995). *

• Linssen A, Meenken C. Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. Am. J. Ophthalmol. 120: 351-361 (1995).

• Lio D, D'Anna C, Gervasi F, Cigna D, Modica MA, Candore G, Caruso C. In vitro impairment of interleukin-5 production in HLA-B8, DR3-positive individuals implications for immunoglobulin A synthesis dysfunction. Hum. Immunol. 44: 170-174 (1995).

• Lippman SM, Heyman RA, Kurie JM, Benner SE, Hong WK. Retinoids and chemoprevention: clinical and basic studies. J. Cell. Biochem. Suppl. 22: 1-10 (1995).

• Liu J, Fujiwara TM, Buu NT, Sanchez FO, Cellier M, Paradis AJ, Frappier D, Skamene E, Gros P, Morgan K, et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am. J. Hum. Genet. 56: 845-853 (1995). *

• Lo D, Reilly C, Marconi LA, Ogata L, Wei Q, Prud'homme G, Kono D, Burkly L. Regulation of CD4 T cell reactivity to self and non-self. Int. Rev. Immunol. 13: 147-160 (1995).

• Loffeld RJ, Overtoom HA, Rauwerda JA. The celiac axis compression syndrome. Report of 5 cases. Digestion 56: 534-537 (1995).

• Loginov AS, Bendikov EA, Petrakov AV. Lipid peroxidation markers in the exhaled breath and microsomal oxidation in patients with chronic diffuse liver diseases. Ter. Arkh. 67: 50-53 (1995).

• Lohse AW, Gerken G, Mohr H, Lohr HF, Treichel U, Dienes HP, Meyer zum Buschenfelde KH. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Z. Gastroenterol. 33: 527-533 (1995).

• Lohse AW, Kogel M, Meyer zum Buschenfelde KH. Evidence for spontaneous immunosuppression in autoimmune hepatitis. Hepatology 22: 381-388 (1995).

• Loomba V, Pawar G, Dhar KL, Setia MS. Serum zinc levels in hepatic encephalopathy. Indian J. Gastroenterol. 14: 51-53 (1995).

• Lu L, Ge Y, Li ZH, Freie B, Clapp DW, Broxmeyer HE. CD34 stem/progenitor cells purified from cryopreserved normal cord blood can be transduced with high efficiency by a retroviral vector and expanded ex vivo with stable integration and expression of Fanconi anemia complementation C gene. Cell Transplant. 4: 493-503 (1995).

• Ludwig J, Colina F, Poterucha JJ. Granulomas in primary sclerosing cholangitis. Liver 15: 307-312 (1995).

• Luo S, Martin BL, Senshu T, Graves DJ. Enzymatic deimination of glycogen phosphorylase and a peptide of the phosphorylation site: identification of modification and roles in phosphorylation and activity. Arch. Biochem. Biophys. 318: 362-369 (1995). *

• Lust JA, Jelinek DF, Donovan KA, Frederick LA, Huntley BK, Braaten JK, Maihle NJ. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R). Curr. Top. Microbiol. Immunol. 194: 199-206 (1995).

• Lyttkens K, Prytz H, Forsberg L, Hagerstrand I. Hepatic lymph nodes as follow-up factor in primary biliary cirrhosis. An ultrasound study. Scand. J. Gastroenterol. 30: 1036-1040 (1995).

• MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J. Rheumatol. 22: 1032-1036 (1995).

• Mack DR, Traystman MD, Colombo JL, Sammut PH, Kaufman SS, Vanderhoof JA, Antonson DL, Markin RS, Shaw BW Jr, Langnas AN. Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis. J. Pediatr. 127: 881-887 (1995). *

• Maclean H, Wright M, Choi D, Tidman MJ. Abnormal night vision with isotretinoin therapy for acne. Clin. Exp. Dermatol. 20: 86 (1995).

• Maggiore G, De Benedetti F, Massa M, Pignatti P, Martini A. Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis. J. Pediatr. Gastroenterol. Nutr. 20: 23-27 (1995).

• Mairal L, de Lima PA, Martin-Comin J, Baliellas C, Xiol X, Roca M, Ricart Y, Ramos M. Simultaneous administration of 111In-human immunoglobulin and 99mTc-HMPAO labelled leucocytes in inflammatory bowel disease. Eur. J. Nucl. Med. 22: 664-670 (1995).

• Majoie CB, Smits NJ, Phoa SS, Reeders JW, Jansen PL. Primary sclerosing cholangitis: sonographic findings. Abdom. Imaging 20: 109-112 (1995).

• Maki M. The humoral immune system in coeliac disease. Baillieres Clin. Gastroenterol. 9: 231-249 (1995).

• Makita T. Molecular organization of hepatocyte peroxisomes. Int. Rev. Cytol. 160: 303-352 (1995).

• Maksymowych WP, Suarez-Almazor M, Chou CT, Russell AS. Polymorphism in the LMP2 gene influences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis. Ann. Rheum. Dis. 54: 321-324 (1995). *

• Malfertheiner P, Mayer D, Buchler M, Dominguez-Munoz JE, Schiefer B, Ditschuneit H. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 36: 450-454 (1995). *

• Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann. Intern. Med. 123: 835-840 (1995).

• Mandak JS, Pollack B, Fishman NO, Furth EE, Kochman ML, Acker MA, Lichtenstein GR. Acalculous candidal cholecystitis: a previously unrecognized complication after cardiac transplantation. Am. J. Gastroenterol. 90: 1333-1337 (1995).

• Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 83: 841-850 (1995). *

• Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell 83: 835-839 (1995). *

• Manji SS, Zhou H, Findlay DM, Martin TJ, Ng KW. Tumor necrosis factor alpha facilitates nuclear actions of retinoic acid to regulate expression of the alkaline phosphatase gene in preosteoblasts. J. Biol. Chem. 270: 8958-8962 (1995). *

• Manolios N, Dunckley H, Chivers T, Brooks P, Englert H. Immunogenetic analysis of 5 families with multicase occurrence of scleroderma and/or related variants. J. Rheumatol. 22: 85-92 (1995).

• Mansfield JC, Giaffer MH, Holdsworth CD. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease. Gut 36: 60-66 (1995). *

• Mansour M, Lassabe G, Rauscher M, Lorentz CH, Nuber AJ, Seronde MF. Pulmonary arterial hypertension and primary biliary cirrhosis. Arch. Mal. Coeur. Vaiss. 88: 503-505 (1995).

• Marasini B, Pipia C, DeValle G, Crosignani A, Petroni L, Cugno M, Zeni S, Bruno S, Bassani C. Vascular impairment in patients with primary biliary cirrhosis. Int. J. Microcirc. Clin. Exp. 15: 75-79 (1995).

• Marcus SL, Miyata KS, Rachubinski RA, Capone JP. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes. Gene Expr. 4: 227-239 (1995).

• Marecek Z. Therapy of chronic cholestasis. Vnitr. Lek. 41: 193-195 (1995).

• Mariette X. Sjogren's syndrome and virus. Ann. Med. Interne. (Paris) 146: 243-246 (1995).

• Marinelli Ibarreta A, Sanchez Movilla A, Izquierdo F, Burgos Lazaro F, Arce Alvarez A, del Castillo-Olivares Ramos JL. Morphopathological changes before and after biliodigestive derivation in experimental cirrhosis induced by biliary ligation in the rat. Rev. Esp. Enferm. Dig. 87: 25-31 (1995).

• Marson P, De Silvestro G. Erythropoietin treatment of thrombocytopenia of chronic liver disease: need for more strictly-defined inclusion and evaluation criteria. J. Hepatol. 23: 232 (1995). *

• Martín MG, Turk E. The molecular basis of inherited disorders of the gastrointestinal and hepatobiliary tracts. An update on recent progress. Gastroenterol. Clin. North Am. 24: 45-70 (1995).

• Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 21: 113-119 (1995).

• Marx J. How the glucocorticoids suppress immunity. Science 270: 232-233 (1995). *

• Masaki N, Hayashi S. Autoimmune liver disease complicating Sjogren's syndrome. Nippon Rinsho 53: 2530-2535 (1995).

• Massardo L, Aguirre V, Garcia ME, Cervila V, Nicovani S, Gonzalez A, Rivero S, Jacobelli S. Clinical expression of rheumatoid arthritis in Chilean patients. Semin. Arthritis Rheum. 25: 203-213 (1995).

• Masuda H, Iwai S, Tanaka T, Hayakawa S. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase. J. Clin. Lab. Immunol. 46: 111-123 (1995).

• Masuichi H, Okawa K, Oka H, Ohba H, Watanabe K, Moriyoshi Y, Kioka K, Nebiki H, So K, Yamada H, et al. Ulcerative colitis in female monozygotic twins. Nippon Shokakibyo Gakkai Zasshi 92: 1966-1970 (1995).

• Matkovits T, Christakos S. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. Mol. Endocrinol. 9: 232-242 (1995). *

• Matsumoto HN, Tamura M, Denhardt DT, Obinata M, Noda M. Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis. Endocrinology 136: 4084-4091 (1995).

• Mattei A, Rucay P, Samuel D, Feray C, Reynes M, Bismuth H. Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration. J. Hepatol. 22: 597 (1995). *

• Maul GG, Yu E, Ishov AM, Epstein AL. Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J. Cell. Biochem. 59: 498-513 (1995).

• Maxton DG, Tweedle DE, Martin DF. Retained common bile duct stones after endoscopic sphincterotomy: temporary and longterm treatment with biliary stenting. Gut 36: 446-449 (1995). *

• Mayall TP, Bjarnason I, Khoo UY, Peters TJ, Macpherson AJ. Mitochondrial gene expression in small intestinal epithelial cells. Biochem. J. 308: 665-671 (1995). *

• McClintock AD, Egan AJ, Woods DJ, Pillans PI. A survey of allopurinol dosage prescribing. N. Z. Med. J. 108: 346-347 (1995).

• McCormick PA, Jenkins SA, McIntyre N, Burroughs AK. Why portal hypertensive varices bleed and bleed: a hypothesis. Gut 36: 100-103 (1995). *

• McDaniel DO, Alarcon GS, Pratt PW, Reveille JD. Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope) Ann. Intern. Med. 123: 181-187 (1995).

• McFarlane XA, Bhalla AK, Reeves DE, Morgan LM, Robertson DA. Osteoporosis in treated adult coeliac disease. Gut 36: 710-714 (1995). *

• McKinnon RA, Burgess WM, Hall PM, Roberts-Thomson SJ, Gonzalez FJ, McManus ME. Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut 36: 259-267 (1995). *

• McPeake J, Williams R. Liver transplantation for hepatocellular carcinoma. Gut 36: 644-646 (1995). *

• Meakem TJ 3rd, Schnall MD. Magnetic resonance cholangiography. Gastroenterol. Clin. North Am. 24: 221-238 (1995).

• Mehal WZ, Culshaw KD, Tillotson GS, Chapman RW. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis. Eur. J. Gastroenterol. Hepatol. 7: 841-845 (1995).

• Mehta DI, Hill ID, Singer-Granick C, Balloch Z, Blecker U. Primary sclerosing cholangitis and multiple autoimmune disorders in a patient with Down syndrome. Clin. Pediatr. (Phila.) 34: 502-505 (1995).

• Meier PJ. Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am. J. Physiol. 269: G801-G812 (1995).

• Mella JG, Roschmann E, Maier KP, Volk BA. Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population. Hepatology 21: 398-402 (1995).

• Mendoza A, Oliff S, Elias E. Hereditary haemorrhagic telangiectasia and secondary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 7: 999-1002 (1995).

• Menon DK, Sargentoni J, Taylor-Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 21: 417-427 (1995).

• Mercado MA, Morales Linares JC, Gomez Mendez TJ, Granados J, Prado E, Orozco H. Complications of splenectomy in the Sugiura-Futagawa procedure. Rev. Gastroenterol. Mex. 60: 145-148 (1995).

• Meyer O. Superantigens and their implication in autoimmune diseases. Presse. Med. 24: 1171-1177 (1995).

• Meyer zum Buschenfelde KH. Immunopathology of chronic liver diseases. Verh. Dtsch. Ges. Pathol. 79: 186-197 (1995).

• Middleton J, Arnott N, Walsh S, Beresford J. Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. Bone 16: 287-293 (1995).

• Middleton SJ, Reynolds PD, Shorthouse M, Hunter JO, Moss S. Nitric oxide synthase in gastric mucosa. Gut 36: 942 (1995). *

• Miettinen TA, Farkkila M, Vuoristo M, Karvonen AL, Leino R, Lehtola J, Friman C, Seppala K, Tuominen J. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine. Hepatology 21: 1261-1268 (1995).

• Mignot E, Kimura A, Abbal M, Thorsby E, Lin X, Voros A, Macaubas C, Bouissou F, Sollid LM, Cambon-Thomsen A, et al. DQCAR microsatellite polymorphisms in three selected HLA class II-associated diseases. Tissue Antigens 46: 299-304 (1995).

• Miki C, Harrison JD, Gunson BK, Buckels JA, McMaster P, Mayer AD. Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation. Br. J. Surg. 82: 1114-1117 (1995).

• Mikkola K, Kiviluoto T, Riihela M, Taavitsainen M, Jarvinen HJ. Liver involvement and its course in patients operated on for ulcerative colitis. Hepatogastroenterology 42: 68-72 (1995).

• Miller LC, Sharma A, McKusick AF, Tassoni JP, Dinarello CA, Kaplan MM. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression. Hepatology 22: 518-524 (1995).

• Mills SJ, Shepherd NA, Hall PA, Hastings A, Mathers JC, Gunn A. Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. Gut 36: 391-394 (1995). *

• Minguez-Mosquera MI, Hornero-Mendez D, Garrido-Fernandez J. Detection of bixin, lycopene, canthaxanthin, and beta-apo-8'-carotenal in products derived from red pepper. J. AOAC Int. 78: 491-496 (1995).

• Minoshima S. Studies on functions of neutrophils in MPO-ANCA related glomerulonephiritis and plasma effect on MPO release from neutrophils. Nippon Jinzo Gakkai Shi 37: 481-490 (1995).

• Mirode A, Tribouilloy C, Boulanger J, Adam MC, Trojette F, Lesbre JP. Pulmonary hypertension associated with portal hypertension. Apropos of 2 cases. Arch. Mal. Coeur. Vaiss. 88: 1647-1650 (1995).

• Mitsuyama K, Toyonaga A, Sasaki E, Ishida O, Ikeda H, Tsuruta O, Harada K, Tateishi H, Nishiyama T, Tanikawa K. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 36: 45-49 (1995). *

• Miyamoto T, Maeda T, Onishi S, Yamamoto Y. T cell autoreactivity against a 28 kD biliary protein (B1-p28) in primary biliary cirrhosis. J. Hepatol. 22: 423-430 (1995). *

• Mizuki N, Inoko H. Human leukocyte antigen (HLA) and the related diseases. Nippon Naika Gakkai Zasshi 84: 2091-2103 (1995).

• Mizuki N, Ohno S, Sato T, Ishihara M, Miyata S, Nakamura S, Naruse T, Mizuki H, Tsuji K, Inoko H. Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behcet's disease. Hum. Immunol. 43: 129-135 (1995).

• Monaco JJ, Nandi D. The genetics of proteasomes and antigen processing. Annu. Rev. Genet. 29: 729-754 (1995). *

• Monowarul Islam SM, Numaga J, Fujino Y, Masuda K, Ohda H, Hirata R, Maeda H, Mitsui H. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum. 38: 547-550 (1995).

• Moore L, Xu X, Davidson G, Moore D, Carli M, Ferrante A. Autoimmune enteropathy with anti-goblet cell antibodies. Hum. Pathol. 26: 1162-1168 (1995).

• Mor F, Cohen IR. Vaccines to prevent and treat autoimmune diseases. Int. Arch. Allergy Immunol. 108: 345-349 (1995).

• Morozzi G, Galeazzi M, Delfino L, Pera C, Ferrara GB, Marcolongo R. Allelic variations of DPB1, DQA1, DQB1 and DRB1 and rheumatoid arthritis: further genetic and statistical considerations. Ann. Ital. Med. Int. 10: 171-174 (1995).

• Mothes T, Bendix U, Pfannschmidt C, Lehmann I. Effect of gliadin and other food peptides on expression of MHC class II molecules by HT-29 cells. Gut 36: 548-552 (1995). *

• Mrowka C, Csernok E, Gross WL, Feucht HE, Bechtel U, Thoenes GH. Distribution of the granulocyte serine proteinases proteinase 3 and elastase in human glomerulonephritis. Am. J. Kidney Dis. 25: 253-261 (1995).

• Mulder AH, Stegeman CA, Kallenberg CG. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA. Clin. Exp. Immunol. 101: 227-232 (1995). *

• Muller AF, Maloney A, Jenkins D, Dowling F, Smith P, Bessell EM, Toghill PJ. Primary gastric lymphoma in clinical practice 1973-1992. Gut 36: 679-683 (1995). *

• Muller AF, Toghill PJ. Hyposplenism in gastrointestinal disease. Gut 36: 165-167 (1995). *

• Muller G, Veyckemans F, Calier M, Van Obbergh LJ, De Kock M, Sokal EM, Otte JB. Anaesthetic considerations in progressive familial intrahepatic cholestasis (Byler's disease). Can. J. Anaesth. 42: 1126-1133 (1995).

• Muller S, Schwartz LM. Ubiquitin in homeostasis, development and disease. Bioessays 17: 677-684 (1995).

• Murata Y, Ishiguro Y, Itoh J, Munakata A, Yoshida Y. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J. Gastroenterol. 30 Suppl. 8: 56-60 (1995).

• Muratori L, Lenzi M, Ma Y, Cataleta M, Mieli-Vergani G, Vergani D, Bianchi FB. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 37: 406-412 (1995). *

• Murillas R, Larcher F, Conti CJ, Santos M, Ullrich A, Jorcano JL. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J. 14: 5216-5223 (1995). *

• Murphy TL, Cleveland MG, Kulesza P, Magram J, Murphy KM. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell. Biol. 15: 5258-5367 (1995). *

• Murray A, Oliaro J, Schlup MM, Chadwick VS. Mycobacterium paratuberculosis and inflammatory bowel disease: frequency distribution in serial colonoscopic biopsies using the polymerase chain reaction. Microbios. 83: 217-228 (1995).

• Nagata T, Weiss EH, Abe K, Kitagawa K, Ando A, Yara-Kikuti Y, Seldin MF, Ozato K, Inoko H, Taketo M. Physical mapping of the retinoid X receptor B gene in mouse and human. Immunogenetics 41: 83-90 (1995).

• Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 109: 1462-1467 (1995). *

• Nakajima H, Munakata A, Yoshida Y. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine. J. Gastroenterol. 30 Suppl. 8: 115-117 (1995).

• Nakamura M, Ishibashi H, Matsui M, Shimoda S, Hayashida K, Koike K, Niho Y. Peripheral B lymphocyte repertoire to mitochondrial antigen in primary biliary cirrhosis - positive correlation between the disease activity and the frequency of circulating B lymphocytes specific for pyruvate dehydrogenase complex. Autoimmunity 21: 253-262 (1995).

• Nakanuma Y, Tsuneyama K, Gershwin ME, Yasoshima M. Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress. Semin. Liver Dis. 15: 313-328 (1995).

• Nakanuma Y, Tsuneyama K, Kono N, Hoso M, Van de Water J, Gershwin ME. Biliary epithelial expression of pyruvate dehydrogenase complex in primary biliary cirrhosis: an immunohistochemical and immunoelectron microscopic study. Hum. Pathol. 26: 92-98 (1995).

• Nakanuma Y, Yasoshima M, Morita T, Gershwin ME. Abnormal expression of pyruvate dehydrogenase on bile ducts opens new fields in the pathogenesis of primary biliary cirrhosis. Nippon Rinsho 53: 1287-1296 (1995).

• Nakayama M, Arai K, Hasegawa K, Sato K, Ohtsuka K, Watanabe H, Sakai K, Rikiishi H, Abo T. Adhesion molecules on intermediate TCR cells. II. Hepatoprotective effects of hyaluronic acid on acute liver injury. Cell. Immunol. 166: 275-285 (1995). *

• Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 22: 451-457 (1995).

• Nathens AB, Rotstein OD, Dackiw AP, Marshall JC. Intestinal epithelial cells down-regulate macrophage tumor necrosis factor-alpha secretion: a mechanism for immune homeostasis in the gut-associated lymphoid tissue. Surgery 118: 343-350 (1995).

• Nau H. Chemical structure - teratogenicity relationships, toxicokinetics and metabolism in risk assessment of retinoids. Toxicol. Lett. 82-83: 975-979 (1995).

• Nelson EA, Gibson B. The management of leg ulcers in a patient with ulcerative colitis. This case study details the treatment of a patient with Pyoderma gangrenosum on the shins of both legs. J. Wound Care 4: 391-393 (1995).

• Neuberger J. Recurrence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis. Liver Transpl. Surg. 1: 109-115 (1995).

• Neuberger J, Wallace L, Joplin R, Hubscher S. Hepatic distribution of E2 component of pyruvate dehydrogenase complex after transplantation. Hepatology 22: 798-801 (1995).

• Newsholme EA, Blomstrand E. Tryptophan, 5-hydroxytryptamine and a possible explanation for central fatigue. Adv. Exp. Med. Biol. 384: 315-320 (1995).

• Ng KW, Zhou H, Manji S, Martin TJ. Regulation and regulatory role of the retinoids. Crit. Rev. Eukaryot. Gene Expr. 5: 219-253 (1995).

• Nicodeme E, Nicaud M, Issandou M. Retinoids stimulate fibrinogen production both in vitro (hepatocytes) and in vivo. Induction requires activation of the retinoid X receptor. Arterioscler. Thromb. Vasc. Biol. 15: 1660-1667 (1995).

• Nierman DM, Kalb TH, Ornstein MH, Gil J. A patient with antineutrophil cytoplasmic antibody-negative pulmonary capillaritis and circulating primed neutrophils. Arthritis Rheum. 38: 1855-1858 (1995).

• Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 101: 428-435 (1995). *

• Nieto A, Blanco Quiros A, Arranz E, Alonso Franch M, Garrote JA, Calvo C. Study of HLA-DQA1 alleles in celiac children. J. Investig. Allergol. Clin. Immunol. 5: 209-215 (1995).

• Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37: 766-776 (1995). *

• Nishi H, Koga Y, Koyanagi T, Harada H, Imaizumi T, Toshima H, Sasazuki T, Kimura A. DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy. J. Mol. Cell. Cardiol. 27: 2385-2392 (1995). *

• Nishimori I, Morita M, Kino J, Onodera M, Nakazawa Y, Okazaki K, Yamamoto Y, Yamamoto Y. Pancreatic involvement in patients with Sjogren's syndrome and primary biliary cirrhosis. Int. J. Pancreatol. 17: 47-54 (1995).

• Nixon DW. Diet and chemoprevention of colon polyps and colorectal cancer. Semin. Surg. Oncol. 11: 411-415 (1995).

• Noda M, Denhardt DT. Regulation of osteopontin gene expression in osteoblasts. Ann. N. Y. Acad. Sci. 760: 242-248 (1995). *

• Nolte W, Polzien F, Sattler B, Ramadori G, Hartmann H. Recurrent episodes of acute hepatitis associated with LKM-1 (cytochrome P450 2D6) antibodies in identical twin brothers. J. Hepatol. 23: 734-739 (1995). *

• Noshiro H, Chijiiwa K, Makino I, Nakano K, Hirota I. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones. Gut 36: 121-125 (1995). *

• Novacek G, Plachetzky U, Potzi R, Lentner S, Slavicek R, Gangl A, Ferenci P. Dental and periodontal disease in patients with cirrhosis - role of etiology of liver disease. J. Hepatol. 22: 576-582 (1995). *

• Nozue T, Kobayashi A, Uemasu F, Takagi Y, Endoh H, Sako A. Plasma endothelin-1 levels of children with cirrhosis. J. Pediatr. Gastroenterol. Nutr. 21: 220-223 (1995).

• Nunez L, Amigo L, Mingrone G, Rigotti A, Puglielli L, Raddatz A, Pimentel F, Greco AV, Gonzalez S, Garrido J, et al. Biliary aminopeptidase-N and the cholesterol crystallisation defect in cholelithiasis. Gut 37: 422-426 (1995). *

• Nuyts GD, Van Vlem E, De Vos A, Daelemans RA, Rorive G, Elseviers MM, Schurgers M, Segaert M, D'Haese PC, De Broe ME. Wegener granulomatosis is associated to exposure to silicon compounds: a case-control study. Nephrol. Dial. Transplant. 10: 1162-1165 (1995).

• O'Brien S, Hatfield AR, Craig PI, Williams SP. A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction. Gut 36: 618-621 (1995). *

• O'Callaghan A, O'Brien SG, Ninkovic M, Butcher GP, Foster CS, Walters JR, Roberts IA. Chronic intrahepatic cholestasis in sickle cell disease requiring exchange transfusion. Gut 37: 144-147 (1995). *

• O'Leary DP. Biliary cholesterol transport and the nucleation defect in cholesterol gallstone formation. J. Hepatol. 22: 239-246 (1995). *

• Odeh M. A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome. Gut 37: 441-443 (1995). *

• Oesterreicher C, Pfeffel F, Petermann D, Muller C. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. J. Hepatol. 23: 396-402 (1995). *

• Ogura T, Kageyama J, Itano Y, Yamauchi T, Oishi T, Aita T, Hayakawa N, Ogasa T, Ota K, Ota Z, et al. Crohn's disease associated with growth hormone secretory dysfunction. Intern. Med. 34: 112-117 (1995). *

• Ohhira M, Ohhira M, Matsumoto A, Ohta H, Okuno K, Okamoto M, Taya N, Namiki M. The development of serum alkaline phosphatase and gamma-glutamyl transpeptidase in early stages of primary biliary cirrhosis. Nippon Shokakibyo Gakkai Zasshi 92: 140-145 (1995).

• Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91 (1995). *

• Olerup O, Olsson R, Hultcrantz R, Broome U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 108: 870-878 (1995). *

• Olive C. T cell receptor usage in autoimmune disease. Immunol. Cell Biol. 73: 297-307 (1995).

• Ollier WE, MacGregor A. Genetic epidemiology of rheumatoid disease. Br. Med. Bull. 51: 267-285 (1995).

• Olsson R, Broome U, Danielsson A, Hagerstrand I, Jarnerot G, Loof L, Prytz H, Ryden BO, Wallerstedt S. Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 108: 1199-1203 (1995). *

• Olsson R, Hagerstrand I, Broome U, Danielsson A, Jarnerot G, Loof L, Prytz H, Ryden BO, Wallerstedt S. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J. Clin. Pathol. 48: 933-935 (1995). *

• Olsson RG, Asztely MS. Prognostic value of cholangiography in primary sclerosing cholangitis. Eur. J. Gastroenterol. Hepatol. 7: 251-254 (1995).

• Onishchenko NA, Bazieva FKh, Orzhekhovskaia IG, Toshchakov VIu, Polosina OV, Danilov MA, Suskova VS. The enhancement of treatment efficacy in chronic liver failure by using hemoperfusion across donor hepatocytes and spleen fragments. Ter. Arkh. 67: 6-9 (1995).

• Ono T, Nagasue N, Kohno H, Uchida M, Takemoto Y, Dhar DK, Nakamura T. Effect of tauroursodeoxycholic acid on bile flow and calcium excretion in ischemia-reperfusion injury of rat livers. J. Hepatol. 23: 582-590 (1995). *

• Oomes PG, Jacobs BC, Hazenberg MP, Banffer JR, van der Meche FG. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barre syndrome: evidence of molecular mimicry. Ann. Neurol. 38: 170-175 (1995).

• Oriishi T, Sata M, Toyonaga A, Sasaki E, Tanikawa K. Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A. Gut 36: 891-896 (1995). *

• Ortiz MA, Piedrafita FJ, Pfahl M, Maki R. TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals. Mol. Endocrinol. 9: 1679-1691 (1995). *

• Oude Elferink RP, Groen AK. The role of mdr2 P-glycoprotein in biliary lipid secretion. Cross-talk between cancer research and biliary physiology. J. Hepatol. 23: 617-625 (1995). *

• Oude Elferink RP, Ottenhoff R, van Wijland M, Smit JJ, Schinkel AH, Groen AK. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J. Clin. Invest. 95: 31-38 (1995). *

• Oudkerk Pool M, Bouma G, Meuwissen SG, von Blomberg BM, van de Merwe JP, Deville WL, Fonk JC, Pena AS. Serological markers to differentiate between ulcerative colitis and Crohn's disease. J. Clin. Pathol. 48: 346-350 (1995). *

• Oudkerk Pool M, Bouma G, Visser JJ, Kolkman JJ, Tran DD, Meuwissen SG, Pena AS. Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand. J. Gastroenterol. 30: 784-788 (1995).

• Pablos JL, Carreira PE, Martin-Villa JM, Montalvo G, Arnaiz-Villena A, Gomez-Reino JJ. Polymorphism of the heat-shock protein gene HSP70-2 in systemic lupus erythematosus. Br. J. Rheumatol. 34: 721-723 (1995).

• Pageaux GP, Blanc P, Perrigault PF, Navarro F, Fabre JM, Souche B, Domergue J, Larrey D, Michel H. Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation. J. Hepatol. 23: 119-122 (1995). *

• Palmer CN, Hsu MH, Griffin HJ, Johnson EF. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270: 16114-16121 (1995). *

• Pan L, Eckhoff C, Brinckerhoff CE. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J. Cell. Biochem. 57: 575-589 (1995).

• Panja A, Siden E, Mayer L. Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells. Clin. Exp. Immunol. 100: 298-305 (1995). *

• Paonessa G, Graziani R, De Serio A, Savino R, Ciapponi L, Lahm A, Salvati AL, Toniatti C, Ciliberto G. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J. 14: 1942-1951 (1995). *

• Parra Blanco JA, Juanco Pedregal C, Silvan Delgado M. Changed hepatic vein flow in patients with cirrhosis. A Doppler study of hepatic veins in patients with cirrhosis. Rev. Esp. Enferm. Dig. 87: 621-623 (1995).

• Parveen S, Morshed SA, Nishioka M. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities. J. Gastroenterol. Hepatol. 10: 438-445 (1995).

• Patel RT, Bain I, Youngs D, Keighley MR. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis. Colon Rectum 38: 831-837 (1995).

• Patel RT, Pall AA, Adu D, Keighley MR. Circulating soluble adhesion molecules in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 7: 1037-1041 (1995).

• Paulsen G, Lundin KE, Gjertsen HA, Hansen T, Sollid LM, Thorsby E. HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201. Hum. Immunol. 42: 145-153 (1995).

• Pawlak J, Malkowski P, Michalowicz B, Zieniewicz K, Nyckowski P, Grzelak I, Schaeffer M, Gackowski W, Karwowski A, Lao M, et al. Orthotopic liver transplantation in a patient with primary biliary cirrhosis. Pol. Tyg. Lek. 50: 53-65 (1995).

• Payne CM, Bernstein H, Bernstein C, Garewal H. Role of apoptosis in biology and pathology: resistance to apoptosis in colon carcinogenesis. Ultrastruct. Pathol. 19: 221-248 (1995).

• Pedersen G, Brynskov J, Nielsen OH, Bendtzen K. Adhesion molecules in inflammatory and neoplastic intestinal diseases. Dig. Dis. 13: 322-336 (1995).

• Pedron T, Girard R, Chaby R. Variation of LPS-binding capacity, epitope expression, and shedding of membrane-bound CD14 during differentiation of human monocytes. J. Immunol. 155: 1460-1471 (1995).

• Pedrosa MC, Rohrer RM, Kaplan MM. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation. Clin. Transplant. 9: 322-325 (1995).

• Peelman LJ, Chardon P, Nunes M, Renard C, Geffrotin C, Vaiman M, Van Zeveren A, Coppieters W, van de Weghe A, Bouquet Y, et al. The BAT1 gene in the MHC encodes an evolutionarily conserved putative nuclear RNA helicase of the DEAD family. Genomics 26: 210-218 (1995).

• Peleg S, Sastry M, Collins ED, Bishop JE, Norman AW. Distinct conformational changes induced by 20-epi analogues of 1 alpha,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor. J. Biol. Chem. 270: 10551-10558 (1995). *

• Perez Garrigues H, Carmona E, Morera C, Sanchez-Cuenca JM. Circulating auto-antibodies in Meniere's disease. Ann. Otolaryngol. Chir. Cervicofac. 112: 225-228 (1995).

• Perlmann T, Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 9: 769-782 (1995). *

• Perman E, Hanauer S, Szeless S, Inoue K, Muts-Homsma S, Rahn S. International forum on ulcerative colitis. Risk selection aspects of ulcerative colitis. J. Insur. Med. 27: 167-180 (1995).

• Piotrowicz A, Polkey M, Wilkinson M. Ursodeoxycholic acid for the treatment of flucloxacillin-associated cholestasis. J. Hepatol. 22: 119-120 (1995). *

• Pirisi M, Fabris C, Soardo G, Cecchin E, Toniutto P, Bartoli E. Thrombocytopenia of chronic liver disease corrected by erythropoietin treatment. J. Hepatol. 23: 233 (1995). *

• Pistorius LR, Sweidan WH, Purdie DW, Steel SA, Howey S, Bennett JR, Sutton DR. Coeliac disease and bone mineral density in adult female patients. Gut 37: 639-642 (1995). *

• Plass C, Weichenhan D, Kunze B, Hellwig T, Schneider C, Bautz FA, Grzeschik KH, Traut W, Winking H. A member of the mouse LRR transcript family with homology to the human Sp100 gene. Hereditas 122: 245-256 (1995).

• Playford RJ. Peptides and gastrointestinal mucosal integrity. Gut 37: 595-597 (1995). *

• Playford RJ, Wright NA, Goodlad RA. Luminal nutrition and gut growth. Gut 36: 943 (1995). *

• Plevris JN, Bouchier IA. Defective acid base regulation by the gall bladder epithelium and its significance for gall stone formation. Gut 37: 127-131 (1995). *

• Ploski R, Flato B, Vinje O, Maksymowych W, Forre O, Thorsby E. Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Hum. Immunol. 44: 88-96 (1995).

• Podevin P, Calmus Y, Bonnefis MT, Veyrunes C, Chereau C, Poupon R. Effect of cholestasis and bile acids on interferon-induced 2',5'-adenylate synthetase and NK cell activities. Gastroenterology 108: 1192-1198 (1995). *

• Pollmacher T, Mullington J, Korth C, Hinze-Selch D. Influence of host defense activation on sleep in humans. Adv. Neuroimmunol. 5: 155-169 (1995).

• Poo JL, Estanes A, Pedraza-Chaverrí J, Cruz C, Uribe M. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats. Ren. Fail. 17: 13-20 (1995).

• Poo JL, Rosas-Romero R, Rodriguez F, Silencio JL, Munoz R, Bourges H, Uribe M. Serum zinc concentrations in two cohorts of 153 healthy subjects and 100 cirrhotic patients from Mexico City. Dig. Dis. 13: 136-142 (1995).

• Pooley N, Ghosh L, Sharon P. Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis. Dig. Dis. Sci. 40: 219-225 (1995).

• Porter SR. Oral lichen planus and chronic liver disease. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 79: 267-268 (1995).

• Portmann B, Slapak GI, Gane E, Williams R. Pathology and biopsy diagnosis of the transplanted liver. Verh. Dtsch. Ges. Pathol. 79: 277-290 (1995).

• Posthuma EF, Westendorp RG, van der Sluys Veer A, Kluin-Nelemans JC, Kluin PM, Lamers CB. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. Gut 36: 311-313 (1995). *

• Potten CS, Owen G, Hewitt D, Chadwick CA, Hendry H, Lord BI, Woolford LB. Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. Gut 36: 864-873 (1995). *

• Poupon R, Poupon RE. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol. Ther. 66: 1-15 (1995). *

• Powrie F, Leach MW. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Ther. Immunol. 2: 115-123 (1995).

• Probert CS, Warren BF, Perry T, Mackay EH, Mayberry JF, Corfield AP. South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover. Gut 36: 696-702 (1995). *

• Propert D. Immunoglobulin allotypes and RFLPs in disease association. Exp. Clin. Immunogenet. 12: 198-205 (1995).

• Propst A, Propst T, Zangerl G, Ofner D, Judmaier G, Vogel W. Prognosis and life expectancy in chronic liver disease. Dig. Dis. Sci. 40: 1805-1815 (1995).

• Przemioslo R, Wright NA, Elia G, Ciclitira PJ. Analysis of crypt cell proliferation in coeliac disease using MI-B1 antibody shows an increase in growth fraction. Gut 36: 22-27 (1995). *

• Przemioslo RT, Lundin KE, Sollid LM, Nelufer J, Ciclitira PJ. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 36: 874-879 (1995). *

• Puxeddu A, Quartini M, Massimetti A, Ferrieri A. Rifaximin in the treatment of chronic hepatic encephalopathy. Curr. Med. Res. Opin. 13: 274-281 (1995).

• Rabinovitz M, Appasamy R, Finkelstein S. Primary biliary cirrhosis diagnosed during pregnancy. Does it have a different outcome? Dig. Dis. Sci. 40: 571-574 (1995).

• Rachmilewitz D, Karmeli F, Okon E, Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37: 247-255 (1995). *

• Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36: 718-723 (1995). *

• Radchenko VG. Plasmapheresis efficacy in the treatment of patients with chronic cholestatic hepatitis and primary biliary liver cirrhosis. Lik. Sprava. 5-6: 160-163 (1995).

• Radema SA, Tytgat GN, van Deventer SJ. In situ detection of interleukin-1 beta and interleukin 8 in biopsy specimens from patients with ulcerative colitis. Adv. Exp. Med. Biol. 371B: 1297-1299 (1995).

• Raedsch R, Plachky J, Wolf N, Simonis G. Biliary lipids, lithogenic index and biliary drug concentrations during etofibrate and bezafibrate treatment. Eur. J. Drug Metab. Pharmacokinet. 20: 113-118 (1995).

• Raiford DS. Pruritus of chronic cholestasis. QJM 88: 603-607 (1995).

• Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 108: 865-869 (1995). *

• Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann. Intern. Med. 123: 925-932 (1995). *

• Raqib R, Lindberg AA, Wretlind B, Bardhan PK, Andersson U, Andersson J. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect. Immun. 63: 289-296 (1995). *

• Remmel T, Remmel H, Uibo R, Salupere V. Primary biliary cirrhosis in Estonia. With special reference to incidence, prevalence, clinical features, and outcome. Scand. J. Gastroenterol. 30: 367-371 (1995).

• Renner EL. Does the primary disease recur following liver transplantation? Ther. Umsch. 52: 572-580 (1995).

• Reumaux D, Meziere C, Colombel JF, Duthilleul P, Mueller S. Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease. Clin. Immunol. Immunopathol. 77: 349-357 (1995). *

• Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86: 3189-3195 (1995). *

• Reyes H, Dearing L, Bick RL, Shoenfeld Y, Peter JB. Laboratory diagnosis of antiphospholipid syndromes. Clin. Lab. Med. 15: 85-108 (1995).

• Reyes H, Ribalta J, Hernandez I, Arrese M, Pak N, Wells M, Kirsch RE. Is dietary erucic acid hepatotoxic in pregnancy? An experimental study in rats and hamsters. Hepatology 21: 1373-1379 (1995).

• Reynolds PD, Middleton SJ, Shorthouse M, Hunter JO. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system. Aliment. Pharmacol. Ther. 9: 491-495 (1995).

• Rhodes J, Coles GA. An alternative view of 5-ASA formulations. Gut 36: 639-640 (1995). *

• Rhodes M, Nathanson L, Fielding G. Laparoscopic biliary and gastric bypass: a useful adjunct in the treatment of carcinoma of the pancreas. Gut 36: 778-780 (1995). *

• Ribalta J, Reyes H, Hernandez I, Fuentes O, Baez M, Gonzalez M, Palma J. Can a selenium deficiency affect the pathogenesis of cholestasis in pregnancy? Gastroenterol. Hepatol. 18: 114-120 (1995).

• Ricci G, D'Ambrosi A, Resca D, Masotti M, Alvisi V. Comparison of serum total sialic acid, C-reactive protein, alpha 1-acid glycoprotein and beta 2-microglobulin in patients with non-malignant bowel diseases. Biomed. Pharmacother. 49: 259-262 (1995).

• Riehl TE, Stenson WF. Platelet-activating factor acetylhydrolases in Caco-2 cells and epithelium of normal and ulcerative colitis patients. Gastroenterology 109: 1826-1834 (1995). *

• Roberts EA. Autoimmune hepatitis. Indian J. Pediatr. 62: 525-531 (1995).

• Rodrigues CM, Kren BT, Steer CJ, Setchell KD. The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation. Gastroenterology 109: 1835-1844 (1995). *

• Rodrigues CM, Kren BT, Steer CJ, Setchell KD. Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate. Gastroenterology 109: 564-572 (1995). *

• Rodriguez-Fragoso L, Gonzalez MP, Muriel P. Interferon-alpha 2b increases fibrolysis in fibrotic livers from bile duct ligated rats: possible participation of the plasminogen activator. Pharmacology 51: 341-346 (1995).

• Roitberg-Tambur A, Witt CS, Friedmann A, Safirman C, Sherman L, Battat S, Nelken D, Brautbar C. Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens 46: 104-110 (1995).

• Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WS, Epstein S. Rapamycin: a bone sparing immunosuppressant? J. Bone Miner. Res. 10: 760-768 (1995).

• Rosenberg WM, Prince C, Kaklamanis L, Fox SB, Jackson DG, Simmons DL, Chapman RW, Trowell JM, Jewell DP, Bell JI. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 345: 1205-1209 (1995).

• Roskell DE, Hyde GM, Campbell AP, Jewell DP, Gray W. HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease. Gut 37: 148-150 (1995). *

• Roussel B, Dubel L, Kantara-Doukoure M, Bernard M, Johanet C. Analysis of dot-blot technique for the detection of three autoantibodies (anti-Jo-1, anti-M2, anti-ribosome). Comparison with reference techniques. Ann. Biol. Clin. (Paris) 53: 487-490 (1995).

• Routsias J, Papadopoulos GK. Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM. Diabetologia 38: 1251-1261 (1995).

• Rowbotham DS, Mapstone NP, Trejdosiewicz LK, Howdle PD, Quirke P. Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction. Gut 37: 660-667 (1995). *

• Rowley S, Candinas D, Mayer AD, Buckels JA, McMaster P, Keighley MR. Restorative proctocolectomy and pouch anal anastomosis for ulcerative colitis following orthotopic liver transplantation. Gut 37: 845-847 (1995). *

• Roy B, Taneja R, Chambon P. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a RXR-specific ligand. Mol. Cell. Biol. 15: 6481-6487 (1995). *

• Rudi J, Waldherr R, Raedsch R, Kommerell B. Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling. J. Hepatol. 22: 43-49 (1995). *

• Rudi J, Waldherr R, Raedsch R, Stremmel W. Serum hepatocyte growth factor levels in primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 7: 1081-1086 (1995).

• Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Boulay G, Bradley A, Birnbaumer L. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat. Genet. 10: 143-150 (1995). *

• Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Bradley A, Birnbaumer L. Gi2 alpha protein deficiency: a model of inflammatory bowel disease. J. Clin. Immunol. 15: 101S-105S (1995).

• Rugtveit J, Haraldsen G, Hogasen AK, Bakka A, Brandtzaeg P, Scott H. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells. Gut 37: 367-373 (1995). *

• Ruiz-Herrera J, Iranzo M, Elorza MV, Sentandreu R, Mormeneo S. Involvement of transglutaminase in the formation of covalent cross-links in the cell wall of Candida albicans. Arch. Microbiol. 164: 186-193 (1995).

• Ryley NG, Fleming KA, Chapman RW. Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin). J. Hepatol. 23: 278-282 (1995). *

• Saeki H, Kuwata S, Nakagawa H, Etoh T, Yanagisawa M, Miyamoto M, Tokunaga K, Juji T, Shibata Y. Analysis of disease-associated amino acid epitopes on HLA class II molecules in atopic dermatitis. J. Allergy Clin. Immunol. 96: 1061-1068 (1995).

• Saeki R, Ogino H, Kaneko S, Unoura M, Kobayashi K. Effects of chenodeoxycholic and ursodeoxycholic acids on interferon-gamma production by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. J. Gastroenterol. 30: 739-744 (1995).

• Sahmoud T, Hoctin-Boes G, Modigliani R, Bitoun A, Colombel JF, Soule JC, Florent C, Gendre JP, Lerebours E, Sylvester R. Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 37: 811-818 (1995). *

• Sanjeevi CB, Landin-Olsson M, Kockum I, Dahlquist G, Lernmark A. Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus. Tissue Antigens 45: 148-152 (1995).

• Sanjeevi CB, Lybrand TP, DeWeese C, Landin-Olsson M, Kockum I, Dahlquist G, Sundkvist G, Stenger D, Lernmark A. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study. Diabetes 44: 125-131 (1995).

• Santos J, Junquera F, de Torres I, Molero X, Vilaseca J, Malagelada JR. Eosinophilic gastroenteritis presenting as ascites and splenomegaly. Eur. J. Gastroenterol. Hepatol. 7: 675-678 (1995).

• Sardesai VM. Role of antioxidants in health maintenance. Nutr. Clin. Pract. 10: 19-25 (1995).

• Sarner M. Pancreatic inflammatory disease. Gut 37: 455-456 (1995). *

• Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol. Clin. North Am. 24: 475-507 (1995).

• Sasakawa T, Takizawa H, Bannai H, Narisawa R, Asakura H. Activated CD4+ and CD8+ cells in the colonic mucosa of ulcerative colitis patients: their relationship to HLA-DR antigen expression on the colonic epithelium and serum soluble CD25 levels. Digestion 56: 516-522 (1995).

• Sasaki H, Harada H, Handa Y, Morino H, Suzawa M, Shimpo E, Katsumata T, Masuhiro Y, Matsuda K, Ebihara K, et al. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Biochemistry 34: 370-377 (1995).

• Sauer P, Kloters-Plachky P, Stiehl A. Inhibition of ileal bile acid transport by cyclosporin A in rat. Eur. J. Clin. Invest. 25: 677-682 (1995).

• Sauter G, Beuers U, Paumgartner G. Effect of dietary fiber on serum bile acids in patients with chronic cholestatic liver disease under ursodeoxycholic acid therapy. Digestion 56: 523-527 (1995).

• Savidge TC, Walker-Smith JA, Phillips AD. Novel insights into human intestinal epithelial cell proliferation in health and disease using confocal microscopy. Gut 36: 369-374 (1995). *

• Savidge TC, Walker-Smith JA, Phillips AD, Savidge TC. Intestinal proliferation in coeliac disease: looking into the crypt. Gut 36: 321-323 (1995). *

• Schafer R, Sheil JM. Superantigens and their role in infectious disease. Adv. Pediatr. Infect. Dis. 10: 369-390 (1995).

• Schatzkin A, Kelloff G. Chemo- and dietary prevention of colorectal cancer. Eur. J. Cancer 31A: 1198-1204 (1995). *

• Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270: 283-286 (1995). *

• Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15: 943-953 (1995). *

• Schmidt C, Kosche E, Baumeister B, Vetter H. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 7: 865-869 (1995).

• Scholmerich J. Current therapeutic possibilities in chronic inflammatory intestinal diseases. Schweiz. Rundsch. Med. Prax. 84: 29-33 (1995).

• Schoonbroodt D, Horsmans Y, Laka A, Geubel AP, Hoang P. Eosinophilic gastroenteritis presenting with colitis and cholangitis. Dig. Dis. Sci. 40: 308-314 (1995).

• Schreiber S, Gehrckens A, Raedler A. Activation of the major omentum-associated lymphoid tissue in Crohn disease. Zentralbl. Chir. 120: 135-144 (1995).

• Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 108: 21-33 (1995). *

• Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108: 1434-1444 (1995). *

• Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis. Nat. Med. 1: 703-705 (1995).

• Schultz DR, Tozman EC. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations. Semin. Arthritis Rheum. 25: 143-159 (1995). *

• Schulzke JD, Schulzke I, Fromm M, Riecken EO. Epithelial barrier and ion transport in coeliac sprue: electrical measurements on intestinal aspiration biopsy specimens. Gut 37: 777-782 (1995). *

• Schumacher G, Kollberg B, Sandstedt B, Ljungh A, Nassberger L. Circulating granulocyte antibodies in first attacks of colitis. Scand. J. Gastroenterol. 30: 157-163 (1995).

• Schurmann GM, Bishop AE, Facer P, Vecchio M, Lee JC, Rampton DS, Polak JM. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut 36: 411-418 (1995). *

• Schworer H, Hartmann H, Ramadori G. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron. Pain 61: 33-37 (1995). *

• Scott BB. Local anaesthetic sprays and pneumonia after gastroscopy. Gut 37: 445 (1995). *

• Scott BB. Gastroenterology in the Trent Region in 1992 and a review of changes since 1975. Gut 36: 468-472 (1995). *

• Scott RJ, van der Luijt R, Spycher M, Mary JL, Muller A, Hoppeler T, Haner M, Muller H, Martinoli S, Brazzola PL, et al. Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes. Gut 36: 731-736 (1995). *

• Sebagh M, Farges O, Kalil A, Samuel D, Bismuth H, Reynes M. Sclerosing cholangitis following human orthotopic liver transplantation. Am. J. Surg. Pathol. 19: 81-90 (1995).

• Sekler I, Lo RS, Kopito RR. A conserved glutamate is responsible for ion selectivity and pH dependence of the mammalian anion exchangers AE1 and AE2. J. Biol. Chem. 270: 28751-28758 (1995). *

• Seol W, Choi HS, Moore DD. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9: 72-85 (1995). *

• Setchell KD, Yamashita H, Rodrigues CM, O'Connell NC, Kren BT, Steer CJ. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism. Biochemistry 34: 4169-4178 (1995).

• Severini A, Mantero S, Tanzi MC, Cigada A, Salvetti M, Cozzi G, Motta A. Polyurethane-coated, self-expandable biliary stent: an experimental study. Acad. Radiol. 2: 1078-1081 (1995).

• Sgonc R, Dietrich H, Gershwin ME, Colombatti A, Wick G. Genomic analysis of collagen and endogenous virus loci in the UCD-200 and 206 lines of chickens, animal models for scleroderma. J. Autoimmun. 8: 763-770 (1995).

• Shah HA, Piris J, Finlayson ND. Primary pulmonary hypertension developing 11 years after a splenorenal shunt for portal hypertension in hepatic cirrhosis. Eur. J. Gastroenterol. Hepatol. 7: 283-286 (1995).

• Shah U, Dasgupta A, Das KM. Development of ulcerative colitis-associated anti-idiotype antibody using a novel monoclonal antibody against a colonic autoantigen. Cell. Immunol. 166: 154-157 (1995).

• Shamsher MK, Navsaria HA, Stevens HP, Ratnavel RC, Purkis PE, Kelsell DP, McLean WH, Cook LJ, Griffiths WA, Gschmeissner S, et al. Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum. Mol. Genet. 4: 1875-1881 (1995).

• Sharp R, Babyatsky MW, Takagi H, Tagerud S, Wang TC, Bockman DE, Brand SJ, Merlino G. Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development 121: 149-161 (1995). *

• Shaw SK, Brenner MB. The beta 7 integrins in mucosal homing and retention. Semin. Immunol. 7: 335-342 (1995). *

• Shefer S, Kren BT, Salen G, Steer CJ, Nguyen LB, Chen T, Tint GS, Batta AK. Regulation of bile acid synthesis by deoxycholic acid in the rat: different effects on cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase. Hepatology 22: 1215-1221 (1995).

• Sheikh SH, Shaw-Stiffel TA. The gastrointestinal manifestations of Sjogren's syndrome. Am. J. Gastroenterol. 90: 9-14 (1995).

• Sheppard DN, Ostedgaard LS, Winter MC, Welsh MJ. Mechanism of dysfunction of two nucleotide binding domain mutations in cystic fibrosis transmembrane conductance regulator that are associated with pancreatic sufficiency. EMBO J. 14: 876-883 (1995). *

• Shiffman ML, Kaplan GD, Brinkman-Kaplan V, Vickers FF. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann. Intern. Med. 122: 899-905 (1995). *

• Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J. Exp. Med. 181: 1835-1845 (1995). *

• Shimokura GH, McGill JM, Schlenker T, Fitz JG. Ursodeoxycholate increases cytosolic calcium concentration and activates Cl- currents in a biliary cell line. Gastroenterology 109: 965-972 (1995). *

• Shingai R, Maeda T, Onishi S, Yamamoto Y. Autoantibody against 70 kD heat shock protein in patients with autoimmune liver diseases. J. Hepatol. 23: 382-390 (1995). *

• Shintani N, Nakajima T, Nagai H, Watanabe M, Kagitani Y, Takizawa H, Asakura H. Immunological effect of immunoglobulin on experimental colitis induced by dextran sulfate. Nippon Shokakibyo Gakkai Zasshi 92: 1911-1921 (1995).

• Shiomi S, Kuroki T, Fujimoto S, Yamaoka M, Sakaguchi H, Takeda T, Nishiguchi S, Nakajima S, Kobayashi K, Ochi H. Primary biliary cirrhosis complicated by severe hypoxemia. J. Gastroenterol. 30: 790-794 (1995).

• Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 21: 106-112 (1995).

• Short AK, Lockwood CM, Bollen A, Moguilevsky N. Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis. Clin. Exp. Immunol. 102: 106-111 (1995). *

• Shpilberg O, Peretz H, Zivelin A, Yatuv R, Chetrit A, Kulka T, Stern C, Weiss E, Seligsohn U. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 85: 429-432 (1995). *

• Silvain C, Zeevi A, Saidman S, Duquesnoy RJ, Van Thiel DH. Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease. Hepatogastroenterology 42: 250-258 (1995).

• Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 37: 71-76 (1995). *

• Silverman JA, Thorgeirsson SS. Regulation and function of the multidrug resistance genes in liver. Prog. Liver Dis. 13: 101-123 (1995).

• Simoni P, Cerre C, Cipolla A, Polimeni C, Pistillo A, Ceschel G, Roda E, Roda A. Bioavailability study of a new, sinking, enteric-coated ursodeoxycholic acid formulation. Pharmacol. Res. 31: 115-119 (1995).

• Simpson KJ, Hayes PC. Soluble adhesion molecules in immune mediated liver disease. Gut 36: 806-808 (1995). *

• Sinaasappel M. Present and future treatment modalities for gastrointestinal diseases in cystic fibrosis. Neth. J. Med. 46: 275-279 (1995).

• Singh K, Saunders JH, Foley RJ. Inflammatory bowel disease in married couples. Gut 37: 158 (1995). *

• Singleton JW, Hanauer S, Robinson M. Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease. Dig. Dis. Sci. 40: 931-935 (1995).

• Sipos P, Guldutuna S, Leuschner U, Vallent K. Comparative study of superoxide production of monocytes in primary biliary cirrhosis. Orv. Hetil. 136: 2389-2392 (1995).

• Sjalander A, Birgander R, Athlin L, Stenling R, Rutegard J, Beckman L, Beckman G. P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 16: 1461-1464 (1995).

• Skarstein K, Wahren M, Zaura E, Hattori M, Jonsson R. Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice. Autoimmunity 22: 9-16 (1995).

• Skov L, Baadsgaard O. Superantigens. Do they have a role in skin diseases? Arch. Dermatol. 131: 829-832 (1995).

• Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375: 802-806 (1995). *

• Smith-Ravin J, England J, Talbot IC, Bodmer W. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 36: 81-86 (1995). *

• Smithson JE, Radford-Smith G, Jewell GP. Appendectomy and tonsillectomy in patients with inflammatory bowel disease. J. Clin. Gastroenterol. 21: 283-286 (1995).

• Sninsky CA. New salicylates as maintenance treatment in ulcerative colitis. Gut 36: 640 (1995). *

• Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM Jr. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology 109: 1249-1256 (1995). *

• Soloway RD, Crowther RS. Bacteria and cholesterol gallstones: molecular biology comes to gallstone pathogenesis. Gastroenterology 108: 934-936 (1995). *

• Sperling RI. Eicosanoids in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 21: 741-758 (1995).

• Sperling W, Kalb R. Psychiatric consultation before liver transplantation. Fortschr. Med. 113: 175-177 (1995).

• Spicakova M, Novakova J, Bartova J, Barot-Ciorbaru R, Tlaskalova H. Immunological study of children with IgA deficiency. Adv. Exp. Med. Biol. 371B: 717-718 (1995).

• Srivastava MD, Rossi TM, Lebenthal E. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus. Res. Commun. Mol. Pathol. Pharmacol. 87: 21-26 (1995).

• Stabler A, Schmidt D, Schnabelmeier H, Reiser M. Fatigue fractures of the sacrum in primary biliary liver cirrhosis. Aktuelle. Radiol. 5: 161-163 (1995).

• Stack WA, Keely SJ, O'Donoghue DP, Baird AW. Immune regulation of human colonic electrolyte transport in vitro. Gut 36: 395-400 (1995). *

• Steenland K, Goldsmith DF. Silica exposure and autoimmune diseases. Am. J. Ind. Med. 28: 603-608 (1995).

• Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation 60: 1057-1060 (1995).

• Steinman L, Waisman A, Altmann D. Major T-cell responses in multiple sclerosis. Mol. Med. Today 1: 79-83 (1995).

• Steinmetz I, Schiffmann P, Brenneke B. Secretory monoclonal IgA class-switch variants against bacterial enteric pathogens in bile and intestinal secretions. FEMS Immunol. Med. Microbiol. 11: 329-336 (1995).

• Stenson WF. Interleukin-4 hyporesponsiveness in inflammatory bowel disease: immune defect or physiological response? Gastroenterology 108: 284-286 (1995). *

• Sternsdorf T, Guldner HH, Szostecki C, Grotzinger T, Will H. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand. J. Immunol. 42: 257-268 (1995).

• Stiehl A. Bile acids in liver diseases - current indications. Ther. Umsch. 52: 682-686 (1995).

• Stiehl A. Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment. Ital. J. Gastroenterol. 27: 193-195 (1995).

• Stiehl A, Rudolph G, Sauer P, Theilmann L. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. J. Hepatol. 23: 283-289 (1995). *

• Stokkers PC, Camoglio L, van Deventer SJ. Tumor necrosis factor (TNF) in inflammatory bowel disease: gene polymorphisms, animal models, and potential for anti-TNF therapy. J. Inflamm. 47: 97-103 (1995).

• Strassburg CP, Manns MP. Autoimmune hepatitis versus viral hepatitis C. Liver 15: 225-232 (1995).

• Strater J, Koretz K, Gunthert AR, Moller P. In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut 37: 819-825 (1995). *

• Strobel S. Mechanisms in adverse reactions to food. Mechanisms of tolerance and sensitization in the intestine and other organs of the body. Allergy 50: S18-S25 (1995).

• Sturgeon JB, Bhatia P, Hermens D, Miner PB Jr. Exacerbation of chronic ulcerative colitis with mesalamine. Gastroenterology 108: 1889-1893 (1995). *

• Suarez-Almazor ME, Tao S, Moustarah F, Russell AS, Maksymowych W. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study. J. Rheumatol. 22: 2027-2033 (1995).

• Suenaga K, Yokoyama Y, Okazaki K, Yamamoto Y. Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease. Am. J. Gastroenterol. 90: 76-80 (1995).

• Sugawara T, Lin D, Holt JA, Martin KO, Javitt NB, Miller WL, Strauss JF 3rd. Structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry 34: 12506-12512 (1995).

• Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Monteil MA, Turner MW. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 345: 886-889 (1995).

• Sung JJ, Leung JC, Tsui CP, Chung SS, Lai KN. Biliary IgA secretion in obstructive jaundice: the effects of endoscopic drainage. Gastrointest. Endosc. 42: 439-444 (1995).

• Suzui M, Yoshimi N, Ushijima T, Hirose Y, Makita H, Wang A, Kawamori T, Tanaka T, Mori H, Nagao M. No involvement of Ki-ras or p53 gene mutations in colitis-associated rat colon tumors induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate. Mol. Carcinog. 12: 193-197 (1995).

• Suzuki A, Sekiyama N, Koito N, Ohosone Y, Mita S, Matsuoka Y, Irimajiri S. Liver disease in systemic lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi 18: 53-59 (1995).

• Suzuki R, Goda T, Takase S. Consumption of excess vitamin A, but not excess beta-carotene, causes accumulation of retinol that exceeds the binding capacity of cellular retinol-binding protein, type II in rat intestine. J. Nutr. 125: 2074-2082 (1995). *

• Suzuki Y, Nakase K, Nagaya S, Tamaki S, Tanigawa M, Ikeda T, Tsuji K, Miyanishi E. Acute promyelocytic leukemia following ulcerative colitis. Rinsho Ketsueki 36: 707-709 (1995).

• Swidsinski A, Ludwig W, Pahlig H, Priem F. Molecular genetic evidence of bacterial colonization of cholesterol gallstones. Gastroenterology 108: 860-864 (1995). *

• Tabona P, Mellor A, Summerfield JA. Mannose binding protein is involved in first-line host defence: evidence from transgenic mice. Immunology 85: 153-159 (1995). *

• Tait BD, Drummond BP, Varney MD, Harrison LC. HLA-DRB1*0401 is associated with susceptibility to insulin-dependent diabetes mellitus independently of the DQB1 locus. Eur. J. Immunogenet. 22: 289-297 (1995).

• Takacs T, Montet JC. In vitro dissolution of cholesterol biliary stones. Gut 37: 157-158 (1995). *

• Take H, Kubota K, Tamura K, Kurabayashi H, Tamura J, Shirakura T. Acquired total immunoglobulin G deficiency in a patient with primary biliary cirrhosis. J. Intern. Med. 238: 289-292 (1995).

• Tanaka H, Maeda T, Onishi S, Yamamoto Y. Humoral and cellular immune responses to dihydrolipoamide dehydrogenase (E3): lack of specificity for primary biliary cirrhosis. Liver 15: 121-125 (1995).

• Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 108: 1159-1166 (1995). *

• Targan SR, Landers CJ, Cobb L, MacDermott RP, Vidrich A. Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J. Immunol. 155: 3262-3267 (1995).

• Targan SR, Murphy LK. Clarifying the causes of Crohn's. Nat. Med. 1: 1241-1243 (1995).

• Tarmin L, Yin J, Harpaz N, Kozam M, Noordzij J, Antonio LB, Jiang HY, Chan O, Cymes K, Meltzer SJ. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res. 55: 2035-2038 (1995). *

• Tartakovsky F, Worman HJ. Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope. Hepatology 21: 495-500 (1995).

• Tassi V, Scarnecchia L, Di Cerbo A, Pirro MT, Di Paola R, Liuzzi A, Torlontano M, Zingrillo M, D'Aloiso L, De Filippis V. A thyroid hormone receptor beta gene polymorphism associated with Graves' disease. J. Mol. Endocrinol. 15: 267-272 (1995).

• Taylor DR, Crowther RS, Cozart JC, Sharrock P, Wu J, Soloway RD. Calcium carbonate in cholesterol gallstones: polymorphism, distribution, and hypotheses about pathogenesis. Hepatology 22: 488-496 (1995).

• te Velde AA, Ladiges NC, Flendrig LM, Chamuleau RA. Functional activity of isolated pig hepatocytes attached to different extracellular matrix substrates. Implication for application of pig hepatocytes in a bioartificial liver. J. Hepatol. 23: 184-192 (1995). *

• Teare JP, Price DA, Foster GR, McBride M, Goldin RD, Main J. Reversible AIDS-related sclerosing cholangitis. J. Hepatol. 23: 209-211 (1995). *

• Teckman J, Perlmutter DH. Conceptual advances in the pathogenesis and treatment of childhood metabolic liver disease. Gastroenterology 108: 1263-1279 (1995). *

• Terasaki S, Nakanuma Y, Hoso M, Ogino H, Unoura M, Kobayashi K, Mizuno Y, Nakagawa H, Shimizu M, Kanai M, et al. Three cases of primary biliary cirrhosis associated with bronchial asthma. J. Gastroenterol. 30: 667-671 (1995).

• Theofilopoulos AN. The basis of autoimmunity: part II. Genetic predisposition. Immunol. Today 16: 150-159 (1995). *

• Thomas GA, Rhodes J, Mani V, Williams GT, Newcombe RG, Russell MA, Feyerabend C. Transdermal nicotine as maintenance therapy for ulcerative colitis. N. Engl. J. Med. 332: 988-992 (1995). *

• Thomas GR, Roberts EA, Walshe JM, Cox DW. Haplotypes and mutations in Wilson disease. Am. J. Hum. Genet. 56: 1315-1319 (1995). *

• Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 345: 1071-1074 (1995).

• Thompson NP, Pounder RE, Wakefield AJ. Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur. J. Gastroenterol. Hepatol. 7: 385-390 (1995).

• Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 108: 1011-1015 (1995). *

• Thomson G. HLA disease associations: models for the study of complex human genetic disorders. Crit. Rev. Clin. Lab. Sci. 32: 183-219 (1995).

• Timbrell JA, Seabra V, Waterfield CJ. The in vivo and in vitro protective properties of taurine. Gen. Pharmacol. 26: 453-462 (1995). *

• Tishler M, Alosachie I, Barka N, Lin HC, Gershwin ME, Peter JB, Shoenfeld Y. Primary Sjogren's syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin. Exp. Rheumatol. 13: 497-500 (1995).

• Tlaskalova-Hogenova H, Farre-Castany MA, Stepankova R, Kozakova H, Tuckova L, Funda DP, Barot R, Cukrowska B, Sinkora J, Mandel L, et al. The gut as a lymphoepithelial organ: the role of intestinal epithelial cells in mucosal immunity. Folia. Microbiol. (Praha.) 40: 385-391 (1995).

• Tokuyama H, Tokuyama Y. Endogenous cytokine expression profiles in retinoic acid-induced IgA production by LPS-stimulated murine splenocytes. Cell. Immunol. 166: 247-253 (1995). *

• Tokuyama H, Tokuyama Y, Nakanishi K. Retinoids inhibit IL-4-dependent IgE and IgG1 production by LPS-stimulated murine splenic B cells. Cell. Immunol. 162: 153-158 (1995). *

• Tomlinson IP, Bodmer WF. The HLA system and the analysis of multifactorial genetic disease. Trends Genet. 11: 493-498 (1995). *

• Torgano G, Vecchi M, Podda M, Zuin M, Arosio E, Battezzati PM, de Franchis R. Primary biliary cirrhosis is associated with specific changes in liver IgG-bearing cell subpopulations. J. Hepatol. 22: 545-550 (1995). *

• Toussirot E, Wendling D. Rheumatoid arthritis: its relationship with HLA DR molecules. Presse. Med. 24: 855-858 (1995).

• Tragnone A, Valpiani D, Miglio F, Elmi G, Bazzocchi G, Pipitone E, Lanfranchi GA. Dietary habits as risk factors for inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 7: 47-51 (1995).

• Trueb M. Autoimmune-associated MHC class II molecules. Hautarzt. 46: 225-227 (1995).

• Truedsson L, Sturfelt G, Johansen P, Nived O, Thuresson B. Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17] J. Rheumatol. 22: 1852-1861 (1995).

• Tsai HH, Dwarakanath AD, Hart CA, Milton JD, Rhodes JM. Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut 36: 570-576 (1995). *

• Tsai YT, Chiang BL, Kao YF, Hsieh KH. Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus. Int. Arch. Allergy Immunol. 106: 235-240 (1995).

• Tsianos EV, Dalekos GN, Tzermias C, Merkouropoulos M, Hatzis J. Hidradenitis suppurativa in Crohn's disease. A further support to this association. J. Clin. Gastroenterol. 20: 151-153 (1995).

• Tsui LC. The cystic fibrosis transmembrane conductance regulator gene. Am. J. Respir. Crit. Care Med. 151: S47-S53 (1995).

• Tsuneyama K, Van de Water J, Leung PS, Cha S, Nakanuma Y, Kaplan M, De Lellis R, Coppel R, Ansari A, Gershwin ME. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 21: 1031-1037 (1995).

• Tsuneyama K, Van De Water J, Van Thiel D, Coppel R, Ruebner B, Nakanuma Y, Dickson ER, Gershwin ME. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis. Hepatology 22: 1440-1446 (1995).

• Twisk J, Hoekman MF, Lehmann EM, Meijer P, Mager WH, Princen HM. Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription. Hepatology 21: 501-510 (1995).

• Uchigata Y, Hirata Y, Omori Y. A novel concept of type VII hypersensitivity introduced by insulin autoimmune syndrome (Hirata's disease) Autoimmunity 20: 207-208 (1995).

• Uhr MR, Schaufelberger HD, Hildebrand P, Beglinger C. Thrombocytes express functional cytokine receptors in patients with Crohn disease and ulcerative colitis. Schweiz. Med. Wochenschr. 125: 970-974 (1995).

• Uibo R, Vorobjova T, Metskula K, Kisand K, Wadstrom T, Kivik T. Association of Helicobacter pylori and gastric autoimmunity: a population-based study. FEMS Immunol. Med. Microbiol. 11: 65-68 (1995).

• Underhill JA, Donaldson PT, Doherty DG, Manabe K, Williams R. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 21: 959-962 (1995).

• Urban T, Maquarre E, Housset C, Chouaid C, Devin E, Lebeau B. Allopurinol hypersensitivity. A possible cause of hepatitis and mucocutaneous eruptions in a patient undergoing antitubercular treatment. Rev. Mal. Respir. 12: 314-316 (1995).

• Vaezi MF, Rustagi PK, Elson CO. Transient protein S deficiency associated with cerebral venous thrombosis in active ulcerative colitis. Am. J. Gastroenterol. 90: 313-315 (1995).

• Valverde MA, O'Brien JA, Sepulveda FV, Ratcliff RA, Evans MJ, Colledge WH. Impaired cell volume regulation in intestinal crypt epithelia of cystic fibrosis mice. Proc. Natl. Acad. Sci. U.S.A. 92: 9038-9041 (1995). *

• van de Meeberg PC, Wolfhagen FH, van Erpecum KJ, van Berge Henegouwen GP. Cholestatic liver diseases: new strategies for prevention and treatment of hepatobiliary and cholestatic diseases. Neth. J. Med. 47: 30-35 (1995).

• Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL, Liu S, Roche TE, Krams SM, Munoz S, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J. Exp. Med. 181: 723-733 (1995). *

• Van Kruiningen HJ. On the use of antibiotics in Crohn's disease. J. Clin. Gastroenterol. 20: 310-316 (1995).

• Van Laethem JL. Use of genetic markers during endoscopic screening and follow-up of gastrointestinal precancerous lesions. Acta Gastroenterol. Belg. 58: 187-192 (1995).

• Van Laethem JL, Deviere J, Bourgeois N, Love J, Gelin M, Cremer M, Adler M. Cholangiographic findings in deteriorating primary sclerosing cholangitis. Endoscopy 27: 223-228 (1995).

• van Miert AS. Pro-inflammatory cytokines in a ruminant model: pathophysiological, pharmacological, and therapeutic aspects. Vet. Q. 17: 41-50 (1995).

• van Milligen de Wit AW, van Deventer SJ, Tytgat GN. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. Am. J. Gastroenterol. 90: 893-900 (1995).

• Van Steenbergen W, Vermylen J. Reversible hypoprothrombinemia in a patient with primary biliary cirrhosis treated with rifampicin. Am. J. Gastroenterol. 90: 1526-1528 (1995).

• Van Thiel DH, Carroll P, Abu-Elmagd K, Rodriguez-Rilo H, Irish W, McMichael J, Starzl TE. Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am. J. Gastroenterol. 90: 455-459 (1995).

• Van Thiel DH, Wright H, Carroll P, Abu-Elmagd K, Rodriguez-Rilo H, McMichael J, Irish W, Starzl TE. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am. J. Gastroenterol. 90: 771-776 (1995).

• Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5: 392-399 (1995). *

• Vandevyver C, Geusens P, Cassiman JJ, Raus J. Peptide transporter genes (TAP) polymorphisms and genetic susceptibility to rheumatoid arthritis. Br. J. Rheumatol. 34: 207-214 (1995).

• Vargas JA, Alvarez-Mon M, Manzano L, Albillos A, Fernandez-Corugedo A, Albarran F, Durantez A. Functional defect of T cells in autoimmune gastritis. Gut 36: 171-175 (1995). *

• Vaughan JH. The Epstein-Barr virus in autoimmunity. Springer Semin. Immunopathol. 17: 203-230 (1995).

• Vaughan JH, Nguyen MD, Valbracht JR, Patrick K, Rhodes GH. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J. Clin. Invest. 95: 1316-1327 (1995). *

• Vazquez JJ, Vazquez M, Idoate MA, Montuenga L, Martinez-Anso E, Castillo JE, Garcia N, Medina JF, Prieto J. Anion exchanger immunoreactivity in human salivary glands in health and Sjogren's syndrome. Am. J. Pathol. 146: 1422-1432 (1995). *

• Vazquez-Abad D, Rothfield NF. Autoantibodies in systemic sclerosis. Int. Rev. Immunol. 12: 145-157 (1995).

• Velez A, Alcala J, Fernandez-Roldan JC. Pyoderma gangrenosum associated with acne conglobata. Clin. Exp. Dermatol. 20: 496-498 (1995).

• Velicia Llames MR, Gonzalez Hernandez JM, Fernandez Orcajo P, Sanz Santacruz C. Symptomatic primary biliary stenosis without cholestasis. Gastroenterol. Hepatol. 18: 330-331 (1995).

• Venkataram MN, White AG, Leeny WA, al Suwaid AR, Daar AS. HLA antigens in Omani patients with vitiligo. Clin. Exp. Dermatol. 20: 35-37 (1995).

• Vento S, Guella L, Mirandola F, Cainelli F, Di Perri G, Solbiati M, Ferraro T, Concia E. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 346: 608-609 (1995).

• Verboeket-van de Venne WP, Westerterp KR, van Hoek B, Swart GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake. Gut 36: 110-116 (1995). *

• Veress B, Lofberg R, Bergman L. Microscopic colitis syndrome. Gut 36: 880-886 (1995). *

• Vidal S, Gros P, Skamene E. Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus. J. Leukoc. Biol. 58: 382-390 (1995). *

• Vidrich A, Lee J, James E, Cobb L, Targan S. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J. Clin. Immunol. 15: 293-299 (1995).

• Villari D, Rubino F, Corica F, Spinella S, Di Cesare E, Longo G, Raimondo G. Bile ductopenia following therapy with sulpiride. Virchows Arch. 427: 223-226 (1995).

• Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur. J. Gastroenterol. Hepatol. 7: 609-614 (1995).

• Vogelsang H, Klamert M, Resch H, Ferenci P. Dietary vitamin D intake in patients with Crohn's disease. Wien. Klin. Wochenschr. 107: 578-581 (1995).

• Vollmar B, Senkel A, Menger MD. In vivo evidence that intercellular adhesion molecule-1 does not mediate endotoxin-induced hepatic leukocyte-endothelial cell interaction. J. Hepatol. 23: 613-616 (1995). *

• Volpe MD R. The pathogenesis of Graves' disease. Endocr. Pract. 1: 103-115 (1995).

• von Herrath MG, Oldstone MB. Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases. Trends Microbiol. 3: 424-430 (1995). *

• Vorechovsky I, Zetterquist H, Paganelli R, Koskinen S, Webster AD, Bjorkander J, Smith CI, Hammarstrom L. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin. Immunol. Immunopathol. 77: 185-192 (1995). *

• Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect. Immun. 63: 3158-3165 (1995). *

• Vuoristo M, Farkkila M, Karvonen AL, Leino R, Lehtola J, Makinen J, Mattila J, Friman C, Seppala K, Tuominen J, et al. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology 108: 1470-1478 (1995). *

• Wahli W, Braissant O, Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more.... Chem. Biol. 2: 261-266 (1995). *

• Wakefield AJ, Ekbom A, Dhillon AP, Pittilo RM, Pounder RE. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 108: 911-916 (1995). *

• Wali RK, Frawley BP Jr, Hartmann S, Roy HK, Khare S, Scaglione-Sewell BA, Earnest DL, Sitrin MD, Brasitus TA, Bissonnette M. Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta. Cancer Res. 55: 5257-5264 (1995). *

• Walters JR, Banks LM, Butcher GP, Fowler CR. Detection of low bone mineral density by dual energy x ray absorptiometry in unsuspected suboptimally treated coeliac disease. Gut 37: 220-224 (1995). *

• Wan YJ, Morimoto M, Thurman RG, Bojes HK, French SW. Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci. 56: 307-317 (1995).

• Wan YJ, Pan T, Wang L, Locker J, Wu TC. 9-cis-Retinoic acid is more effective than all-trans-retinoic acid in upregulating expression of the alpha-fetoprotein gene. J. Mol. Endocrinol. 14: 101-108 (1995).

• Wang F, Li X, Annis B, Faustman DL. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA class I expression in type I diabetic cells. Hum. Gene Ther. 6: 1005-1017 (1995).

• Wang MG, Szebeni J, Pearson DA, Szot GL, Sykes M. Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells. Transplantation 60: 481-490 (1995).

• Wang Y, Holland JF, Bleiweiss IJ, Melana S, Liu X, Pelisson I, Cantarella A, Stellrecht K, Mani S, Pogo BG. Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res. 55: 5173-5179 (1995). *

• Ward SJ, Morriss-Kay GM. Distribution of all-trans-, 13-cis- and 9-cis-retinoic acid to whole rat embryos and maternal serum following oral administration of a teratogenic dose of all-trans-retinoic acid. Pharmacol. Toxicol. 76: 196-201 (1995).

• Warren KG, Catz I. Administration of myelin basic protein synthetic peptides to multiple sclerosis patients. J. Neurol. Sci. 133: 85-94 (1995).

• Warren KG, Catz I, Steinman L. Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features. Proc. Natl. Acad. Sci. U.S.A. 92: 11061-11065 (1995). *

• Watanabe H, Ohira H, Kuroda M, Takagi T, Ishikawa H, Nishimaki T, Kasukawa R, Takahashi K. Primary sclerosing cholangitis with marked eosinophilic infiltration in the liver. J. Gastroenterol. 30: 524-528 (1995).

• Watanabe T, Suzuki H, Sawada Y, Naito M, Tsuruo T, Inaba M, Hanano M, Sugiyama Y. Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats. J. Hepatol. 23: 440-448 (1995). *

• Watanabe Y, Mori S, Fujiyama S, Sato T, Mori M. Clinical evaluation of serum ornithine carbamoyltransferase by enzyme-linked immunosorbent assay in patients with liver diseases. Enzyme Protein 48: 18-26 (1995).

• Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270: 985-988 (1995). *

• Waters DL, Dorney SF, Gruca MA, Martin HC, Howman-Giles R, Kan AE, De Silva M, Gaskin KJ. Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency. Hepatology 21: 963-969 (1995).

• Watson PF, French A, Pickerill AP, McIntosh RS, Weetman AP. Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease. J. Clin. Endocrinol. Metab. 80: 1032-1035 (1995). *

• Watson RG, Angus PW, Dewar M, Goss B, Sewell RB, Smallwood RA. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. Gut 36: 927-930 (1995). *

• Weetman AP. Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity. Baillieres Clin. Endocrinol. Metab. 9: 157-174 (1995).

• Wei S, Charmley P, Birchfield RI, Concannon P. Human T-cell receptor V beta gene polymorphism and multiple sclerosis. Am. J. Hum. Genet. 56: 963-969 (1995). *

• Welder AA, Robertson JW, Melchert RB. Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. J. Pharmacol. Toxicol. Methods 33: 187-195 (1995).

• Weldon MJ, Joseph AE, French A, Saverymuttu SH, Maxwell JD. Comparison of 99m technetium hexamethylpropylene-amine oxime labelled leucocyte with 111-indium tropolonate labelled granulocyte scanning and ultrasound in the diagnosis of intra-abdominal abscess. Gut 37: 557-564 (1995). *

• Weldon MJ, Masoomi AM, Britten AJ, Gane J, Finlayson CJ, Joseph AE, Maxwell JD. Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT). Gut 36: 243-250 (1995). *

• Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J. Exp. Med. 182: 1159-1162 (1995). *

• Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies against constituents of nuclear pore complexes in patients with primary biliary cirrhosis and autoimmune hepatitis. Acta Biochim. Pol. 42: 197-200 (1995).

• Whitfield GK, Hsieh JC, Jurutka PW, Selznick SH, Haussler CA, MacDonald PN, Haussler MR. Genomic actions of 1,25-dihydroxyvitamin D3. J. Nutr. 125: 1690S-1694S (1995). *

• Whyte J, Soriano E, Earnshaw WC, McHugh NJ. Frequency of autoantibodies to a major epitope on the carboxyl terminal fragment of CENP-B in patients with autoimmune disease. Br. J. Rheumatol. 34: 407-412 (1995).

• Wiedermann U, Hanson LA, Bremell T, Kahu H, Dahlgren UI. Increased translocation of Escherichia coli and development of arthritis in vitamin A-deficient rats. Infect. Immun. 63: 3062-3068 (1995). *

• Wietholtz H, Zysset T, Marschall HU, Generet K, Matern S. The influence of rifampin treatment on caffeine clearance in healthy man. J. Hepatol. 22: 78-81 (1995). *

• Wiik A, Stummann L, Kjeldsen L, Borregaard N, Ullman S, Jacobsen S, Halberg P. The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens. Clin. Exp. Immunol. 101 Suppl. 1: 15-17 (1995). *

• Wilcox MH, Howe R. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. J. Antimicrob. Chemother. 36: 673-679 (1995).

• Williams SG, Evanson JE, Barrett N, Hodson ME, Boultbee JE, Westaby D. An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis. J. Hepatol. 22: 513-521 (1995). *

• Williams SG, Westaby D. Recent advances in the endoscopic management of variceal bleeding. Gut 36: 647-648 (1995). *

• Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9: 1033-1045 (1995). *

• Wilmer A, Nolchen B, Tilg H, Herold M, Pechlaner C, Judmaier G, Dietze O, Vogel W. Serum neopterin concentrations in chronic liver disease. Gut 37: 108-112 (1995). *

• Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St Louis P, Griffiths AM, Blendis LM, Moroz SP, Scully L, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 22: 1415-1422 (1995).

• Wilschanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H, Durie PR. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J. Pediatr. 127: 705-710 (1995). *

• Wilson AG, Clay FE, Crane AM, Cork MJ, Duff GW. Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis. J. Invest. Dermatol. 104: 856-858 (1995).

• Wirth HP, Zala G, Meyenberger C, Ammann R. Significance of subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis for prognostic parameters and response to ursodeoxycholic acid. Schweiz. Med. Wochenschr. 125: 750-754 (1995).

• Wolf G. A regulatory pathway of thermogenesis in brown fat through retinoic acid. Nutr. Rev. 53: 230-231 (1995).

• Wolfhagen FH, van Buuren HR, Schalm SW, ten Kate FJ, van Hattum J, Eskens FA, den Ouden Muller JW, de Vries RA, Ferwerda J, van der Hoek EW, et al. Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis? The Dutch Multicentre PBC Study Group. J. Hepatol. 22: 381 (1995). *

• Wong HR, Doughty LA, Wedel N, White M, Nelson BJ, Havrilla N, Carcillo JA. Plasma bactericidal/permeability-increasing protein concentrations in critically ill children with the sepsis syndrome. Pediatr. Infect. Dis. J. 14: 1087-1091 (1995).

• Wong SN, Shah V, Dillon MJ. Anti-neutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus. Eur. J. Pediatr. 154: 43-45 (1995).

• Wright DH. The major complications of coeliac disease. Baillieres Clin. Gastroenterol. 9: 351-369 (1995).

• Xia B, Bouma G, Grusius JB, Meuwissen SG, Pena AS. Distribution of an NcoI polymorphism in the lymphotoxin alpha gene in Dutch patients with inflamatory bowel diseases. Chin. Med. J. (Engl.) 108: 739-742 (1995).

• Xiao JH, Durand B, Chambon P, Voorhees JJ. Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. Binding of ligands to RAR only is sufficient for RAR-RXR heterodimers … J. Biol. Chem. 270: 3001-3011 (1995). *

• Yamagata S, Muto T, Uchida Y, Masaki T, Higuchi Y, Sawada T, Hirooka T. Polypoid growth and K-ras codon 12 mutation in colorectal cancer. Cancer 75: 953-957 (1995).

• Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. 80: 41-45 (1995). *

• Yang H, Vora DK, Targan SR, Toyoda H, Beaudet AL, Rotter JI. Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology 109: 440-448 (1995). *

• Yang P, Jarnerot G, Danielsson D, Tysk C, Lindberg E. p-ANCA in monozygotic twins with inflammatory bowel disease. Gut 36: 887-890 (1995). *

• Yang Y, Minucci S, Ozato K, Heyman RA, Ashwell JD. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J. Biol. Chem. 270: 18672-18677 (1995). *

• Yang YZ, Subauste JS, Koenig RJ. Retinoid X receptor alpha binds with the highest affinity to an imperfect direct repeat response element. Endocrinology 136: 2896-2903 (1995). *

• Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155: 5483-5486 (1995).

• Yasoshima M, Nakanuma Y, Tsuneyama K, Van de Water J, Gershwin ME. Immunohistochemical analysis of adhesion molecules in the micro-environment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis. J. Pathol. 175: 319-325 (1995).

• Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br. Heart J. 73: 209-215 (1995).

• Yen JH, Chen JR, Tsai WJ, Tsai JJ, Liu HW. HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. J. Rheumatol. 22: 1450-1454 (1995).

• Yeum KJ, Lee-Kim YC, Yoon S, Lee KY, Park IS, Lee KS, Kim BS, Tang G, Russell RM, Krinsky NI. Similar metabolites formed from beta-carotene by human gastric mucosal homogenates, lipoxygenase, or linoleic acid hydroperoxide. Arch. Biochem. Biophys. 321: 167-174 (1995). *

• Yokoyama WM. Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc. Natl. Acad. Sci. U.S.A. 92: 3081-3085 (1995). *

• Yoshida EM, Scudamore CH, Erb SR, Owen DA, Silver HK. Markedly elevated serum CA 19-9 levels in a case of chronic pancreatitis. Can. J. Surg. 38: 83-86 (1995).

• Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig. Dis. Sci. 40: 1561-1568 (1995).

• Yoshida SH, Swan S, Teuber SS, Gershwin ME. Silicone breast implants: immunotoxic and epidemiologic issues. Life Sci. 56: 1299-1310 (1995).

• Yoshioka R, Sato Y, Kogure A, Ohira H, Takagi T, Kuroda M, Miyata M, Obara K, Nishimaki T, Kasukawa R. Association of primary sclerosing cholangitis, thymoma and hypogammaglobulinemia. Liver 15: 53-55 (1995).

• Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, McMahon G, Brown M, Lazar MA. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270: 23975-23983 (1995). *

• Yuan G, Shi G, Ding Y. Serum anti-subtypical Klebsiella pneumoniae antibodies in ankylosing spondylitis. Zhonghua Nei Ke Za Zhi 34: 193-195 (1995).

• Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol. 154: 3025-3035 (1995).

• Zajicek G, Shamir R, Nordenberg J, Sidi Y, Arber N. Increased turnover of intrahepatic bile ducts induced by bromobenzene. Dig. Dis. Sci. 40: 730-733 (1995).

• Zandi P, Panis Y, Debray D, Bernard O, Houssin D. Pediatric liver transplantation for Langerhans' cell histiocytosis. Hepatology 21: 129-133 (1995).

• Zelissen PM, Bast EJ, Croughs RJ. Associated autoimmunity in Addison's disease. J. Autoimmun. 8: 121-130 (1995).

• Zhang RW, Supowit SC, Xu X, Li H, Christensen MD, Lozano R, Simmons DJ. Expression of selected osteogenic markers in the fibroblast-like cells of rat marrow stroma. Calcif. Tissue Int. 56: 283-291 (1995).

• Zhao MH, Jones SJ, Lockwood CM. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin. Exp. Immunol. 99: 49-56 (1995). *

• Zhao Z, Ross AC. Retinoic acid repletion restores the number of leukocytes and their subsets and stimulates natural cytotoxicity in vitamin A-deficient rats. J. Nutr. 125: 2064-2073 (1995). *

• Zhou H, Glimcher LH. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2: 545-553 (1995).

• Zhou SR, Moscarello MA, Whitaker JN. The effects of citrullination or variable amino-terminus acylation on the encephalitogenicity of human myelin basic protein in the PL/J mouse. J. Neuroimmunol. 62: 147-152 (1995).

• Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Annu. Rev. Genet. 29: 777-807 (1995). *

• Zimmer KP, Poremba C, Weber P, Ciclitira PJ, Harms E. Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes. Gut 36: 703-709 (1995). *

• Zimmermann H, Ganz P, Zimmermann A, Oguey D, Marti U, Reichen J. The overexpression of proliferating cell nuclear antigen in biliary cirrhosis in the rat and its relationship with epidermal growth factor receptor. J. Hepatol. 23: 459-464 (1995). *

• Zimmermann-Seydoux G, Rontogianni D, Zimmermann A. Primary biliary cirrhosis. Localization of antigen-presenting cells in piecemeal necroses. Pathologe 16: 262-268 (1995).

• Zins BJ, Sandborn WJ, Penna CR, Landers CJ, Targan SR, Tremaine WJ, Wiesner RH, Dozois RR. Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis. Am. J. Gastroenterol. 90: 2177-2181 (1995).

Number of references = 1023

www psc-literature.org